Data / Research funding / Cannabinoid Research
Cannabinoid Research: 831 NIH awards ($917M) to 232 organizations
831 NIH awards ($917M) in the NIH spending category Cannabinoid Research, to 232 organizations, read 2026-11-04. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 831 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Cannabidiol in the treatment of opioid use disorder | NIH | National Institute on Drug Abuse | 2024 | $10,316,590 | September 30, 2019 | August 31, 2027 | HURD, YASMIN L. | reporter.nih.gov |
| LifeâÂÂs end Benefits of CannaBidol and TetrahYdrocannabinol (LiBBY) Trial | NIH | National Institute on Aging | 2021 to 2022 | $9,892,823 | September 15, 2020 | April 30, 2026 | MINTZER, JACOBO | reporter.nih.gov |
| Rocky Mountain Cannabis Research Center | NIH | National Institute on Drug Abuse | 2023 to 2025 | $8,380,548 | September 1, 2023 | June 30, 2028 | HUTCHISON, KENT E. | reporter.nih.gov |
| Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure | NIH | National Institute on Drug Abuse | 2023 to 2025 | $7,084,951 | May 15, 2023 | March 31, 2028 | NDHLOVU, LISHOMWA C | reporter.nih.gov |
| Impact of Cannabinoid Across the Lifespan (ICAL) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $6,925,926 | July 1, 2018 | April 30, 2029 | PIOMELLI, DANIELE | reporter.nih.gov |
| Development of a Longitudinal Observational Research Registry for the Study of Medicinal Cannabis Use and Health | NIH | National Institute on Drug Abuse | 2023 to 2025 | $6,116,522 | June 1, 2023 | April 30, 2028 | VANDREY, RYAN G | reporter.nih.gov |
| CB1 Neutral Antagonists for Alcohol Use Disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $5,965,782 | September 20, 2020 | August 31, 2025 | MAKRIYANNIS, ALEXANDROS | reporter.nih.gov |
| Clinical Trials Network: Pacific Northwest Node (CTN-0082, -0131, -0139 and dissemination library) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $5,664,540 | March 1, 2025 | February 29, 2032 | HATCH, MARY AKIKO | reporter.nih.gov |
| Continued follow-up of the Vitamin C and Smoking in Pregnancy (VCSIP) cohorts through the ECHO consortium, focus on Echo-wide protocols, respiratory outcomes, airway function, and epigenetic changes | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $5,158,536 | September 21, 2016 | May 31, 2030 | MCEVOY, CYNTHIA T | reporter.nih.gov |
| Advancement of AEF0117 as a potential treatment for Cannabis Use Disorder: Preclinical toxicity and Clinical pharmacokinetic studies | NIH | National Institute on Drug Abuse | 2021 to 2023 | $4,483,517 | September 15, 2021 | July 31, 2025 | LEVIN, FRANCES RUDNICK | reporter.nih.gov |
| Translational Studies of Cannabis Administration, Cognition, and the Endocannabinoid System in HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,324,439 | May 1, 2021 | July 31, 2026 | MINASSIAN, ARPI | reporter.nih.gov |
| ADHD diagnosis in adulthood: Implications for cannabis use and consequences | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,942,681 | July 1, 2020 | May 31, 2030 | MOLINA, BROOKE S.G. | reporter.nih.gov |
| Evaluation of Cannabidiol for Reduction of Brain Neuroinflammation | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,931,875 | June 1, 2021 | March 31, 2027 | LOGGIA, MARCO LUCIANO | reporter.nih.gov |
| PRODUCTION, ANALYSIS, AND DISTRIBUTION OF CANNABIS AND RELATED MATERIALS. POP: MARCH 23, 2015 - MARCH 22, 2023. N01DA-15-7793. | NIH | National Institute on Drug Abuse | 2021 to 2022 | $3,928,369 | March 23, 2015 | March 22, 2023 | ELSOHLY, MAHMOUD | reporter.nih.gov |
| Understanding the links between parental and adolescent substance use:complementary natural experiments using the children of twins design | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,871,138 | May 1, 2022 | February 28, 2027 | RHEE, SOO H | reporter.nih.gov |
| The Effects of Cannabis Legalization and Persistent Use: A Longitudinal Study of Two Twin Cohorts | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,800,554 | September 1, 2017 | April 30, 2029 | ELLINGSON, JARROD MARTIN | reporter.nih.gov |
| Heavy cannabis use, neurocognition and PrEP care engagement among young Black sexual minority men | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,790,453 | September 15, 2022 | June 30, 2027 | SCHNEIDER, JOHN | reporter.nih.gov |
| Modeling HIV Microglia-Associated Infection and Inflammation in a Chimeric Mouse Brain | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,747,870 | August 1, 2021 | May 31, 2027 | AKBARIAN, SCHAHRAM | reporter.nih.gov |
| Cannabis and Pathogenic Mechanisms influencing Blood Brain Barrier Function in HIV | NIH | National Institute on Drug Abuse | 2023 to 2025 | $3,726,178 | August 15, 2023 | June 30, 2028 | IUDICELLO, JENNIFER E | reporter.nih.gov |
| Cannabis use, PrEP and HIV transmission risk | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,624,329 | August 1, 2021 | May 31, 2027 | DUNCAN, DUSTIN T | reporter.nih.gov |
| Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids and Neuroinflammation in HIV | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,584,464 | June 15, 2022 | March 31, 2027 | ELLIS, RONALD J. | reporter.nih.gov |
| Risk and Resilience in Urban Black American Acute Trauma Survivors | NIH | National Institute of Mental Health | 2021 to 2025 | $3,579,657 | September 16, 2021 | July 31, 2027 | LARSON, CHRISTINE L | reporter.nih.gov |
| Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty – a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $3,579,362 | September 18, 2023 | August 31, 2028 | BRUMMETT, CHAD M | reporter.nih.gov |
| Origin of Cortical Species-specific Distinctions | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,571,176 | April 1, 2025 | March 31, 2030 | RAKIC, PASKO | reporter.nih.gov |
| Recreational Marijuana Marketing and Young Adult Consumer Behavior | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,562,253 | April 1, 2022 | February 28, 2027 | BERG, CARLA J | reporter.nih.gov |
| Inter- and Intra-cellular effects of cannabinoids, HIV and ART in the CNS | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,529,874 | August 1, 2020 | May 31, 2027 | JORDAN-SCIUTTO, KELLY L | reporter.nih.gov |
| Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2024 | $3,503,395 | June 1, 2020 | March 31, 2026 | RIZZO, STACEY J | reporter.nih.gov |
| Molecular underpinnings of the developmental Effects of Cannabis | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,375,521 | August 15, 2022 | May 31, 2027 | HURD, YASMIN L. | reporter.nih.gov |
| Longitudinal assessment of benefits and harms of cannabis use among community-based cancer patients during initial cancer treatment | NIH | National Cancer Institute | 2023 to 2025 | $3,343,401 | September 19, 2023 | August 31, 2028 | POTOSKY, ARNOLD L | reporter.nih.gov |
| ALCOHOL POLICY INFORMATION SYSTEM | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $3,328,286 | January 1, 2018 | February 10, 2023 | HERRON, KATHERYN | reporter.nih.gov |
| Assessing the Effects of Cigar and Cigarillo Social Media Promotion on Tobacco and Marijuana Use | NIH | National Cancer Institute | 2021 to 2025 | $3,291,137 | December 2, 2020 | November 30, 2026 | KOSTYGINA, GANNA | reporter.nih.gov |
| Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection | NIH | National Institute on Drug Abuse | 2021 to 2024 | $3,267,557 | September 30, 2020 | June 30, 2026 | MOHAN, MAHESH | reporter.nih.gov |
| Vaping Nicotine and Cannabis Across Adolescence and Young Adulthood | NIH | National Cancer Institute | 2021 to 2024 | $3,258,517 | September 20, 2019 | August 31, 2025 | LEVENTHAL, ADAM MATTHEW | reporter.nih.gov |
| Prenatal Cannabis Exposure (PreCE) and Immune-Endocannabinoid Pathways to Development of Offspring Brain and Behavior up to Age 6 | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,245,617 | April 1, 2019 | March 31, 2030 | ROGERS, CYNTHIA ELISE | reporter.nih.gov |
| The Impact of Cannabis Route of Administration and Co-Administration of Alcohol on Impairment | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,228,792 | August 1, 2021 | May 31, 2027 | SPINDLE, TORY RICHARD | reporter.nih.gov |
| Effects of full-spectrum cannabidiol on alcohol consumption and alcohol use disorder phenotypes: implications for precision medicine | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $3,227,517 | September 20, 2025 | August 31, 2029 | KAROLY, HOLLIS C | reporter.nih.gov |
| Peripherally-restricted non-addictive cannabinoids for cancer pain treatment | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $3,174,343 | August 1, 2023 | July 31, 2025 | SPIGELMAN, IGOR | reporter.nih.gov |
| ERP studies of acute influences of THC and CBD on memory encoding and retrieval processes | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,173,683 | August 1, 2021 | May 31, 2027 | CURRAN, TIMOTHY E | reporter.nih.gov |
| Neural and Behavioral Consequences of Chronic THC Exposure During Adolescence | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,173,342 | July 1, 2019 | March 31, 2030 | BERGMAN, JACK | reporter.nih.gov |
| Modulation of pain mechanisms by cannabis-derived phytochemicals. | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,150,461 | December 1, 2020 | November 30, 2026 | SETO, TODD B | reporter.nih.gov |
| Medical Marijuana, Emerging Adults, and Community: Connecting Health and Policy | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,112,216 | July 1, 2013 | January 31, 2029 | LANKENAU, STEPHEN E | reporter.nih.gov |
| Gabapentin for Restoring GABA/glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Clinical MRI Study | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,103,371 | September 15, 2021 | June 30, 2026 | PRISCIANDARO, JAMES JOSEPH | reporter.nih.gov |
| Discriminative Stimulus Effects of Opioid Withdrawal | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,097,773 | May 1, 1995 | December 31, 2026 | FRANCE, CHARLES P | reporter.nih.gov |
| Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and ß-caryophyllene | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,089,484 | February 15, 2020 | January 31, 2026 | COOPER, ZIVA D | reporter.nih.gov |
| Life Course Perspective on Alcohol and Drug Use Trajectories from Adolescence into Adulthood | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,081,005 | August 1, 2021 | April 30, 2027 | D'AMICO, ELIZABETH J. | reporter.nih.gov |
| Cannabis and Nicotine Co-Use Influences on Protracted Development of Neural Structure and Function | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,058,239 | August 15, 2021 | May 31, 2027 | JACOBUS, JOANNA | reporter.nih.gov |
| Cannabis use among older adults: Potential risks and benefits to an aging population | NIH | National Institute on Aging | 2021 to 2025 | $3,055,285 | February 15, 2021 | January 31, 2027 | BRYAN, ANGELA | reporter.nih.gov |
| CHOICES-TEEN: Efficacy of a Bundled Risk Reduction Intervention for Juvenile Justice Females | NIH | National Institute on Drug Abuse | 2021 to 2024 | $3,036,233 | May 15, 2021 | March 31, 2025 | PARRISH, DANIELLE ELIZABETH | reporter.nih.gov |
| Determining the impact of cannabis use and severity on tobacco cessation outcomes: A prospective tobacco treatment trial | NIH | National Cancer Institute | 2021 to 2025 | $3,018,031 | July 1, 2019 | August 31, 2027 | MCCLURE, ERIN A | reporter.nih.gov |
| The role of cannabinoids in the regulation of the blood brain barrier in the context of NeuroHIV and anti-retroviral therapy | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,992,059 | April 1, 2021 | December 31, 2025 | PERSIDSKY, YURI | reporter.nih.gov |
| Effects of cannabis on age-related cognitive decline and Alzheimers disease pathology | NIH | National Institute on Aging | 2021 to 2025 | $2,987,650 | August 15, 2021 | May 31, 2027 | SETLOW, BARRY | reporter.nih.gov |
| Development of KLS-13019 for Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,970,772 | September 30, 2021 | August 31, 2025 | BRENNEMAN, DOUGLAS ERIC | reporter.nih.gov |
| Cannabis, HIV and Mental Processing Systems (CHAMPS) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,959,350 | August 1, 2021 | May 31, 2027 | ANCES, BEAU M | reporter.nih.gov |
| Prenatal cannabis: A fetal neuroimaging study of neurodevelopment | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,937,376 | September 1, 2021 | June 30, 2027 | POSNER, JONATHAN E | reporter.nih.gov |
| RBP2 Biology and Pathobiology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,929,487 | June 15, 2019 | May 31, 2027 | BLANER, WILLIAM S | reporter.nih.gov |
| Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,903,097 | September 1, 2022 | August 31, 2025 | LU, DAI | reporter.nih.gov |
| Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement) | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $2,902,023 | September 15, 2019 | June 30, 2025 | HE, ZHIGANG | reporter.nih.gov |
| Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics | NIH | National Institute on Drug Abuse | 2024 to 2025 | $2,883,639 | September 30, 2020 | August 31, 2026 | PAPPAS, GEORGE | reporter.nih.gov |
| Cannabinoid interactions with central and peripheral pain mechanisms in osteoarthritis of the knee | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $2,864,374 | August 1, 2020 | May 31, 2026 | HARTE, STEVEN EDWARD | reporter.nih.gov |
| Investigating the effect of oral microbiome on cognition in HIV-infected chronic cannabis users | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,858,390 | September 30, 2022 | July 31, 2027 | FITTING, SYLVIA | reporter.nih.gov |
| Opioid and cannabinoid interactions in pain and reward | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,852,096 | September 30, 2020 | June 30, 2026 | NEUBERT, JOHN K | reporter.nih.gov |
| Mechanism of Cannabidiol Effects on HIV Expression, Neuroinflammation, and HIV Cognitive Disease in Chronically-infected Immunocompetent Mice | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,851,386 | September 30, 2020 | July 31, 2025 | VOLSKY, DAVID J | reporter.nih.gov |
| Targeting insomnia to improve outcomes in adults with problematic cannabis use | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,829,587 | September 15, 2022 | July 31, 2027 | ARNEDT, J. TODD | reporter.nih.gov |
| Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study | NIH | National Cancer Institute | 2022 to 2025 | $2,815,567 | April 15, 2022 | March 31, 2027 | MEGHANI, SALIMAH H. | reporter.nih.gov |
| Do hippocampal synaptic density deficits in cannabis use disorder improve following abstinence? | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,803,054 | September 15, 2021 | June 30, 2026 | D'SOUZA, DEEPAK CYRIL | reporter.nih.gov |
| Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,790,999 | May 1, 2021 | February 28, 2027 | BRUEHL, STEPHEN | reporter.nih.gov |
| Addressing disparities in tobacco-related diseases by understanding the tobacco industry strategies | NIH | National Cancer Institute | 2022 to 2025 | $2,769,201 | August 1, 2022 | July 31, 2027 | BIALOUS, STELLA AGUINAGA | reporter.nih.gov |
| Context, Subjective and Cognitive Experiences with Patterns of Tobacco and Cannabis Co-Use in Young Adults | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,763,381 | July 1, 2020 | April 30, 2026 | MERMELSTEIN, ROBIN J. | reporter.nih.gov |
| Cannabis Effects on Antiretroviral Therapy, Pharmacokinetics, and Neurotoxicity | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,756,681 | July 1, 2020 | April 30, 2026 | LETENDRE, SCOTT L | reporter.nih.gov |
| A Multi-Method Investigation of Cannabis Messaging: Characterizing Source, Content, and Associations with Cannabis Consumption | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,751,134 | July 15, 2022 | April 30, 2027 | METRIK, JANE | reporter.nih.gov |
| Real-Time and Long-Term Effects of Medical Marijuana on Older Adults: A Prospective Cohort Study | NIH | National Institute on Aging | 2022 to 2025 | $2,747,244 | February 15, 2022 | November 30, 2026 | WANG, YAN | reporter.nih.gov |
| Cannabis use following trauma exposure: An observational study of the impact of acute stress and fear response on cannabis outcomes | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,737,372 | August 15, 2022 | May 31, 2027 | NUGENT, NICOLE R | reporter.nih.gov |
| Using Behavioral Economics Approach to Examine Individual Preferences for Marijuana Products | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,728,893 | September 30, 2020 | June 30, 2026 | SHI, YUYAN | reporter.nih.gov |
| Mechanisms of cannabidiol in persons with MS: the role of sleep and pain phenotype | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $2,725,289 | August 15, 2021 | May 31, 2026 | BRALEY, TIFFANY JOY | reporter.nih.gov |
| The impact of excise tax structures for retail marijuana on marijuana consumption | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,723,262 | May 15, 2022 | March 31, 2027 | SHANG, CE | reporter.nih.gov |
| Assessing pharmacokinetic and pharmacodynamic variability of Δ9-tetrahydrocannabinol delivered from vaping products with and without concurrent use of nicotine | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,720,537 | September 30, 2022 | June 30, 2027 | SMITH, DANIELLE | reporter.nih.gov |
| Administrative Supplement: Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,712,570 | September 30, 2021 | June 30, 2026 | GILMAN, JODI | reporter.nih.gov |
| Identifying specific genetic pathway interactions for drug use and abuse through integrative omics | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,712,000 | September 1, 2021 | July 31, 2027 | PENG, QIAN | reporter.nih.gov |
| Suppression of Pathological Spontaneous Cortical Dynamics and Inflammation in NeuroHIV | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,709,962 | April 1, 2022 | January 31, 2027 | WILSON, TONY W. | reporter.nih.gov |
| Assessing the Impact of Cannabis Legalization on Adolescent Cannabis Use and Cannabis-Related Health Conditions | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,686,123 | May 1, 2022 | February 28, 2027 | YOUNG-WOLFF, KELLY CORINNE | reporter.nih.gov |
| Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,671,024 | April 1, 2022 | March 31, 2027 | METRIK, JANE | reporter.nih.gov |
| Understanding airway mucus dysfunction in population-based studies | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,669,952 | August 15, 2022 | July 31, 2027 | DIAZ, ALEJANDRO | reporter.nih.gov |
| Type II Afferents and Cochlear Damage | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,635,121 | June 16, 2017 | June 30, 2028 | GLOWATZKI, ELISABETH | reporter.nih.gov |
| Cannabis use frequency and its impact on monocyte-mediated inflammation in HIV patients | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,570,020 | September 1, 2021 | July 31, 2027 | KAMINSKI, NORBERT E | reporter.nih.gov |
| Postsynaptic roles of ankyrins | NIH | National Institute of Mental Health | 2022 to 2025 | $2,559,284 | March 1, 2015 | March 31, 2027 | PENZES, PETER | reporter.nih.gov |
| Local Circuit Control of Rapid Plasticity and Tunable Ensemble Formation in the Hippocampus | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,554,313 | September 1, 2023 | August 31, 2026 | LOSONCZY, ATTILA | reporter.nih.gov |
| Cannabis, inflammation, and the brain in persons with HIV | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,527,684 | September 30, 2020 | June 30, 2025 | IUDICELLO, JENNIFER E | reporter.nih.gov |
| Cannabinoid CB2 Receptor Structure and Allosteric Modulators | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,521,841 | July 15, 2021 | April 30, 2026 | XIE, XIANG-QUN | reporter.nih.gov |
| Drug-gene-nutraceutical interactions of cannabidiol | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $2,519,234 | February 22, 2022 | January 31, 2027 | EADON, MICHAEL THOMAS | reporter.nih.gov |
| Impact of in utero Marijuana Exposure on Neurodevelopment, Behavior and Mental Health: A Longitudinal Birth Cohort Study | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,517,690 | July 1, 2020 | April 30, 2027 | AVALOS, LYNDSAY AMMON | reporter.nih.gov |
| A randomized clinical trial: Examining a brief parent-intervention to reduce college student drinking and cannabis use | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,497,753 | September 15, 2022 | August 31, 2027 | TURRISI, ROBERT J | reporter.nih.gov |
| Fetal cerebral arteries and prenatal alcohol exposure | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,492,106 | March 15, 2022 | January 31, 2027 | BUKIYA, ANNA | reporter.nih.gov |
| Novel Approaches to Opiate Use Reduction | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,469,078 | April 1, 2020 | January 31, 2026 | HUTCHISON, KENT E. | reporter.nih.gov |
| Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024 | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,395,895 | July 1, 2019 | April 30, 2026 | HASIN, DEBORAH S | reporter.nih.gov |
| Teen Mothers’ Prenatal Cannabis Use and Co-Use with Tobacco | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,383,979 | May 1, 2019 | August 31, 2025 | DE GENNA, NATACHA | reporter.nih.gov |
| Hemp-derived Cannabidiol for the treatment of cannabis use disorder in concentrate users: A double-blind placebo-controlled randomized trial | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,376,018 | September 15, 2023 | July 31, 2028 | BIDWELL, L. CINNAMON | reporter.nih.gov |
| Leveraging Social Media to Develop the Cannabis Exposure Index (CEI), A Standardized Measure of Cannabis Use | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,362,528 | September 30, 2020 | July 31, 2025 | BORODOVSKY, JACOB T | reporter.nih.gov |
| Trajectories of Cannabis Use in Pregnancy | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,362,340 | September 30, 2022 | July 31, 2027 | MARK, KATRINA | reporter.nih.gov |
| Translating CBD Treatment for Heroin Addiction | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,349,864 | August 1, 2019 | June 30, 2025 | HURD, YASMIN L. | reporter.nih.gov |
| Synaptic transport of endocannabinoids in the brain | NIH | National Institute of Mental Health | 2021 to 2024 | $2,349,284 | April 1, 2021 | February 28, 2026 | HAJ-DAHMANE, SAMIR | reporter.nih.gov |
| Cannabinoid Receptors and Associated Proteins-Renewal | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,347,872 | August 15, 2017 | March 31, 2028 | HOWLETT, ALLYN C | reporter.nih.gov |
| Quorum Sensing Regulation of EHEC Virulence Genes | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,346,135 | January 1, 2023 | December 31, 2027 | SPERANDIO, VANESSA | reporter.nih.gov |
| Endogenous Cannabinoid Control of Reward Substrates | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,320,372 | March 1, 2008 | April 30, 2027 | CHEER, JOSEPH F | reporter.nih.gov |
| The Impact of Product Packaging on Appeal, Knowledge and Risk Perceptions of Cannabis Edibles | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,319,378 | April 15, 2022 | February 28, 2027 | REBOUSSIN, BETH A. | reporter.nih.gov |
| Examining the synergistic effects of cannabis and prescription opioid policies on chronic pain, opioid prescribing, and opioid overdose | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,319,128 | January 1, 2019 | November 30, 2025 | CERDA, MAGDALENA | reporter.nih.gov |
| Cellular Mechanisms in Fetal Alcohol Spectrum Disorders | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,304,997 | December 15, 2018 | May 31, 2029 | PARNELL, SCOTT | reporter.nih.gov |
| Cannabis Legalization a Decade Later: A Longitudinal Study of Teens, Young Adults, and Parents in Washington State | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,304,978 | July 1, 2022 | April 30, 2027 | BAILEY, JENNIFER A | reporter.nih.gov |
| Looking into the Heart of Cannabis and HIV | NIH | National Institute on Drug Abuse | 2022 | $2,302,500 | April 1, 2022 | March 31, 2026 | MARTINEZ, CLAUDIA | reporter.nih.gov |
| The Impact of Cannabidiol (CBD) Health Claims at Point-of-Sale on Consumer Perceptions and Behavior | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,287,873 | July 15, 2021 | May 31, 2027 | WAGONER, KIMBERLY G. | reporter.nih.gov |
| A machine learning framework for understanding impacts on the HIV latent reservoir size, including drugs of abuse | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,284,375 | September 30, 2021 | June 30, 2027 | RUDIN, CYNTHIA | reporter.nih.gov |
| PRODUCTION OF CANNABIS AND RELATED MATERIALS FOR RESEARCH. MARCH 23, 2023 - APRIL 22, 2023. TASK ORDER 75N95023F00001 (TO1) | NIH | National Institute on Drug Abuse | 2023 | $2,283,969 | March 23, 2023 | April 22, 2023 | ELSOHLY, MAHMOUD | reporter.nih.gov |
| Peripheral and Central Pathways of α3 Glycine Receptors as Non-Opioid Molecular Targets to Treat Pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,282,554 | May 1, 2022 | January 31, 2027 | XU, YAN | reporter.nih.gov |
| Pathogenesis of Neuroinflammation and Neurocognitive Impairment In HIV-infected Young Adult Cannabis Users | NIH | National Institute on Drug Abuse | 2022 to 2024 | $2,280,760 | June 15, 2019 | May 31, 2026 | MURDOCH, DAVID MARTIN | reporter.nih.gov |
| Silencing of astrocytic MAGL as a therapy for Alzheimer’s disease | NIH | National Institute on Aging | 2023 | $2,278,287 | April 15, 2023 | March 31, 2026 | CHEN, CHU | reporter.nih.gov |
| Cannabidiol and Macrophage Chronic Inflammation in a Virally Suppressed Rhesus Macaque Model | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,266,058 | September 30, 2020 | June 30, 2025 | WILLIAMS, DIONNA WHITNEY | reporter.nih.gov |
| Identification of gene variants mediating the behavioral and physiological response to THC | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,243,926 | July 1, 2023 | April 30, 2028 | MULLIGAN, MEGAN KATHLEEN | reporter.nih.gov |
| 2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation | NIH | National Institute of Mental Health | 2022 to 2025 | $2,237,917 | June 15, 2016 | March 31, 2026 | PATEL, SACHIN | reporter.nih.gov |
| Exercise facilitation of adolescent fear extinction, frontolimbic circuitry, and endocannabinoids | NIH | National Institute of Mental Health | 2023 to 2025 | $2,230,303 | July 15, 2023 | April 30, 2028 | MARUSAK, HILARY | reporter.nih.gov |
| The Effect of Medical Cannabis Laws on Health Care Use in Insured Populations with Pain | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,228,671 | July 1, 2019 | April 30, 2026 | ABRAHAM, AMANDA J | reporter.nih.gov |
| Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling | NIH | National Cancer Institute | 2021 to 2025 | $2,219,816 | August 5, 2021 | July 31, 2026 | KHASABOV, SERGEY G | reporter.nih.gov |
| Endocannabinoid Targeting for Opioid Induced Respiratory Depression | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,190,554 | July 1, 2022 | June 30, 2027 | MILNES, TALLY MARIE | reporter.nih.gov |
| Monitoring acute and longer-term effects of cannabis on psychomotor performance in daily life in medical cannabis patients | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,187,146 | August 15, 2023 | June 30, 2029 | CHUNG, TAMMY | reporter.nih.gov |
| Understanding the clinical pharmacology of marijuana-tobacco co-administration | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,179,609 | May 15, 2023 | February 29, 2028 | ST.HELEN, GIDEON | reporter.nih.gov |
| High-throughput Identification of Non-hallucinogenic Psychoplastogens for Treating Addiction | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,172,679 | May 15, 2022 | February 28, 2027 | OLSON, DAVID E | reporter.nih.gov |
| The Effects of Cannabinoids and Route of Cannabis Administration on Subclinical Cardiovascular Disease Risk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,169,132 | August 1, 2020 | June 30, 2025 | VIDOT, DENISE CHRISTINA | reporter.nih.gov |
| The Dopamine Synapse and Associative Learning | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,161,538 | July 1, 1991 | December 31, 2028 | SULZER, DAVID | reporter.nih.gov |
| Endocannabinoids in neurodegenerative diseases | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,151,868 | June 15, 2012 | April 30, 2026 | CHEN, CHU | reporter.nih.gov |
| ÚNETE: Combining Friendship Support Networks and Targeted Messaging from Celebrity Influencers to Reduce Latinx Substance Use Disparities | NIH | National Institute on Drug Abuse | 2023 to 2024 | $2,149,000 | August 1, 2023 | June 30, 2025 | KANAMORI NISHIMURA, MARIANO JUAN | reporter.nih.gov |
| Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial | NIH | National Institute on Aging | 2023 to 2025 | $2,143,253 | July 1, 2023 | June 30, 2028 | HUTCHISON, KENT E. | reporter.nih.gov |
| Effects of chronic marijuana use on endothelial function | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,140,358 | July 1, 2023 | April 30, 2028 | SPRINGER, MATTHEW LAWRENCE | reporter.nih.gov |
| Neurobehavioral Effects of Frequent Co-use of Alcohol and Cannabis | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,133,552 | September 30, 2023 | June 30, 2028 | ANSELL, EMILY B | reporter.nih.gov |
| Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Opioid Abuse Potential and Opioid Safety | NIH | National Institute on Drug Abuse | 2022 to 2024 | $2,125,460 | April 15, 2022 | February 28, 2027 | BABALONIS, SHANNA | reporter.nih.gov |
| Sex-dependent effects of cannabis: Assessing abuse-related and pharmacokinetic differences between men and women | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,123,819 | September 15, 2019 | June 30, 2026 | COOPER, ZIVA D | reporter.nih.gov |
| Development of cannabinoid-opioid combination with opioid sparing and synergistic analgesic effects to prevent opioid use disorder and overdose. | NIH | National Institute on Drug Abuse | 2021 to 2022 | $2,110,556 | September 30, 2019 | August 31, 2025 | BRIONES, MARISA | reporter.nih.gov |
| Regulation of synaptic plasticity by BDNF-endocannabinoid interactions | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,110,192 | December 1, 2019 | November 30, 2026 | LEVINE, ERIC S | reporter.nih.gov |
| Testing a multistage model of risk factors for cannabis use utilizing a measurement burst design | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,107,552 | July 1, 2023 | August 31, 2028 | DYAR, CHRISTINA | reporter.nih.gov |
| Sleep-dependent synaptic homeostasis in Alzheimer's disease | NIH | National Institute on Aging | 2021 | $2,106,477 | April 15, 2021 | March 31, 2024 | DIERING, GRAHAM HUGH | reporter.nih.gov |
| Impact of Reduced Cannabis Use on Functional Outcomes | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,105,439 | September 1, 2018 | November 30, 2024 | KIMBREL, NATHAN A. | reporter.nih.gov |
| Mechanistic Inflammatory Pathways in Graft Versus Host Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,100,486 | August 1, 2020 | May 31, 2026 | DROBYSKI, WILLIAM R. | reporter.nih.gov |
| Impact of maternal marijuana use on epigenetic regulation of offspring neurodevelopment | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,100,000 | September 15, 2022 | August 31, 2027 | LO, JAMIE | reporter.nih.gov |
| Brain and behavior correlates of prenatal cannabis exposure | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,095,376 | July 15, 2023 | May 31, 2028 | KLEINHANS, NATALIA M | reporter.nih.gov |
| Endocannabinoid-Based Treatment for the Neurologic Niemann-Pick Diseases | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,087,153 | September 9, 2022 | August 31, 2027 | SCHUCHMAN, EDWARD H. | reporter.nih.gov |
| Modeling CNS dynamics in HIV infection and cannabinoids with forebrain organoids | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,085,642 | August 1, 2019 | June 30, 2025 | JORDAN-SCIUTTO, KELLY L | reporter.nih.gov |
| Effects of Personally Relevant Stressful Experiences on Alcohol and Cannabis Use | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,082,111 | September 15, 2023 | July 31, 2027 | LUI, P. PRISCILLA | reporter.nih.gov |
| Individual, contextual, and geospatial influences on decisions to drive under the influence of cannabis | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,078,362 | August 1, 2023 | June 30, 2028 | METRIK, JANE | reporter.nih.gov |
| Prenatal alcohol/cannabinoid co-exposures and fetal brain development | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $2,076,761 | May 1, 2020 | April 30, 2026 | MIRANDA, RAJESH C | reporter.nih.gov |
| Life’s end Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Open-Label Extension (OLE) Study | NIH | National Institute on Aging | 2025 | $2,072,617 | August 15, 2025 | July 31, 2028 | MINTZER, JACOBO | reporter.nih.gov |
| Role of endocannabinoid signaling in a preference/aversion circuitry | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,063,766 | April 15, 2022 | January 31, 2027 | GUO, SU | reporter.nih.gov |
| Maternal Marijuana Use During Pregnancy, Marijuana Legalization, and Adverse Obstetrical and Neonatal Outcomes: A 12-year Cohort Study | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,061,059 | July 1, 2019 | April 30, 2025 | YOUNG-WOLFF, KELLY CORINNE | reporter.nih.gov |
| SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $2,054,674 | September 1, 2021 | August 31, 2024 | KORMAN, TYLER P | reporter.nih.gov |
| Effects of High Potency Cannabis Products on Mental Health and Psychosocial Functioning | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,053,256 | May 15, 2023 | March 31, 2028 | HOPFER, CHRISTIAN J | reporter.nih.gov |
| Modulating Signaling Endocannabinoids and Fatty Acid Amides | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,053,125 | December 1, 2021 | November 30, 2026 | BOGER, DALE L | reporter.nih.gov |
| Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $2,051,325 | September 20, 2023 | July 31, 2025 | KIMLESS, DEBRA | reporter.nih.gov |
| Impact of Recreational and Medical Marijuana legalization on cannabis use disorders, serious mental illness, and mortality outcomes among Medicaid enrolled youth | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,046,397 | August 1, 2023 | June 30, 2028 | FONTANELLA, CYNTHIA ANN | reporter.nih.gov |
| A Multimethod Examination of Individual and Environmental Contributors to Cannabis Use and Related Problems | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,044,093 | July 1, 2023 | May 31, 2028 | PEDERSEN, SARAH L | reporter.nih.gov |
| Preclinical Assessment of Medications for Alcohol Abuse | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $2,042,668 | September 28, 2007 | March 31, 2025 | WEERTS, ELISE M | reporter.nih.gov |
| Cell-type based epigenomic analysis to identify druggable genes for people living with HIV infection and using cannabis | NIH | National Institute on Drug Abuse | 2024 to 2025 | $2,031,509 | September 30, 2024 | July 31, 2029 | XU, KE | reporter.nih.gov |
| Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,030,405 | April 20, 2022 | March 31, 2027 | HUTCHISON, KENT E. | reporter.nih.gov |
| Policy and Training Intervention in Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $2,013,739 | September 10, 2025 | August 31, 2026 | WOODALL, W GILL | reporter.nih.gov |
| In vivo study of THC-induced immunogenome changes at single cell resolution in HIV-infected humans | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,010,652 | September 30, 2020 | June 30, 2027 | XU, KE | reporter.nih.gov |
| Novel approaches to assessing cannabis impaired driving | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,006,137 | July 1, 2020 | October 31, 2025 | BROOKS-RUSSELL, ASHLEY | reporter.nih.gov |
| Novel fluorescent sensors for imaging neuromodulation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,001,408 | August 15, 2019 | May 31, 2024 | DAN, YANG | reporter.nih.gov |
| Therapeutic antibodies for treating liver fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $1,999,998 | June 1, 2020 | July 31, 2025 | SCHWIMMER, LAUREN JENNIFER | reporter.nih.gov |
| A microbial engineering platform for sustainable, scalable, and cost-effective production of pharmaceutical grade cannabinoids and related compounds | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $1,999,908 | May 16, 2024 | April 30, 2026 | KAMBOURAKIS, SPIROS | reporter.nih.gov |
| Defining the impact of cannabinoids on the latent HIV reservoir through multi-omic analysis | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,995,250 | July 1, 2021 | May 31, 2024 | BROWNE, EDWARD P | reporter.nih.gov |
| Age-and sex-dependent pharmacodynamics and pharmacokinetics of oral and smoked delta-9-THC | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,994,603 | September 30, 2022 | June 30, 2028 | COOPER, ZIVA D | reporter.nih.gov |
| Treating Young Adult Cannabis Use Disorder with Text Message-Delivered Peer Network Counseling | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,983,271 | August 1, 2019 | May 31, 2026 | MASON, MICHAEL JON | reporter.nih.gov |
| Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain | NIH | National Cancer Institute | 2021 to 2022 | $1,979,001 | September 25, 2019 | April 30, 2025 | SCHWIMMER, LAUREN JENNIFER | reporter.nih.gov |
| Modeling the effects of chronic marijuana use on neuroinflammation and HIV-related neuronal injury | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,976,642 | September 30, 2020 | June 30, 2023 | MEADE, CHRISTINA S | reporter.nih.gov |
| A Longitudinal EMA Study Examining the Role of Maternal Mood and Physical Symptoms on Women's Cannabis Use Across the Perinatal Period | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,973,547 | September 30, 2023 | June 30, 2028 | BATTLE, CYNTHIA L. | reporter.nih.gov |
| Sensitivity to Cannabis Effects and Cue Reactivity as Markers of a Developing Disorder in Adolescents | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,952,293 | May 15, 2023 | February 28, 2028 | TRELOAR PADOVANO, HAYLEY | reporter.nih.gov |
| The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Delta-9THC-Infused Cannabis Edibles | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,951,453 | September 30, 2022 | June 30, 2027 | SPINDLE, TORY RICHARD | reporter.nih.gov |
| Modes of Cannabis Administration and Polysubstance Use among Women Before and During Pregnancy | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,940,849 | September 30, 2023 | July 31, 2028 | YOUNG-WOLFF, KELLY CORINNE | reporter.nih.gov |
| Allosteric Modulation of the CB1 Receptor | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,940,546 | April 1, 2023 | March 31, 2028 | ZHANG, YANAN | reporter.nih.gov |
| Effect of Cannabis Use on Alcohol Craving and Consumption among those in Alcohol Treatment | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,939,671 | September 15, 2023 | June 30, 2028 | GUNN, RACHEL LYN | reporter.nih.gov |
| Endocannabinoid Signaling during Early Pregnancy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,933,902 | July 1, 1990 | May 31, 2026 | DEY, SUDHANSU K | reporter.nih.gov |
| Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics | NIH | National Cancer Institute | 2023 to 2025 | $1,930,054 | September 21, 2023 | August 31, 2028 | REBOUSSIN, BETH A. | reporter.nih.gov |
| Placental Genomics in the Developmental Consequences of Marijuana Use in Pregnancy | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,916,774 | June 1, 2023 | March 31, 2028 | STROUD, LAURA R | reporter.nih.gov |
| Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC | NIH | National Cancer Institute | 2023 to 2025 | $1,915,200 | August 1, 2023 | July 31, 2028 | BRYAN, ANGELA | reporter.nih.gov |
| Endocannabinoid Modulation of the Habenular Stress Response | NIH | National Institute of Mental Health | 2021 to 2025 | $1,912,500 | December 1, 2020 | October 31, 2026 | MCLAUGHLIN, RYAN JOSEPH | reporter.nih.gov |
| Lipid transport in the intestine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,906,281 | May 1, 1987 | March 31, 2027 | STORCH, JUDITH | reporter.nih.gov |
| Assessing benefits and harms of cannabis use in patients treated with immunotherapy for cancer: a prospective cohort study | NIH | National Cancer Institute | 2023 to 2025 | $1,905,214 | September 15, 2023 | August 31, 2028 | ASHARE, REBECCA | reporter.nih.gov |
| Endocannabinoids regulate microglia in developing brain | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,904,331 | April 1, 2016 | February 28, 2027 | MCCARTHY, MARGARET M. | reporter.nih.gov |
| The impact of cannabis and tobacco/nicotine product co-use in young adults: Prospective cessation evaluation and substitution | NIH | National Cancer Institute | 2023 to 2025 | $1,892,323 | September 1, 2023 | August 31, 2028 | MCCLURE, ERIN A | reporter.nih.gov |
| Development of an intravenous CB1 antagonist for acute cannabinoid intoxication and cannabis hyperemesis syndrome | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,886,590 | August 1, 2024 | July 31, 2026 | CUNDY, KENNETH | reporter.nih.gov |
| Fatty acid binding-proteins and endocannabinoids in the retina; roles in glial reactivity and reprogramming of Muller glia into progenitor cells | NIH | National Eye Institute | 2021 to 2025 | $1,880,088 | January 1, 2021 | November 30, 2026 | FISCHER, ANDY J | reporter.nih.gov |
| Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,866,314 | September 30, 2023 | July 31, 2028 | D'SOUZA, DEEPAK CYRIL | reporter.nih.gov |
| Maternal Marijuana Use and Adverse Perinatal Outcomes | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,863,597 | September 30, 2020 | July 31, 2025 | METZ, TORRI D | reporter.nih.gov |
| Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,847,120 | July 1, 2020 | May 31, 2026 | LAKSHMANA, MADEPALLI KRISHNAPPA | reporter.nih.gov |
| Endocannabinoid Metabolism in Acute Pain | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,844,228 | April 15, 2020 | February 28, 2026 | KACZOCHA, MARTIN | reporter.nih.gov |
| HIV-1 Neurotoxicity: Mechanism & Modulation by Cannabinoids | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,839,474 | March 15, 1992 | February 28, 2026 | THAYER, STANLEY A | reporter.nih.gov |
| Use of Focused ultrasound stimulated blood brain barrier opening for CNS HIV/SIV reservoir reduction | NIH | National Institute on Drug Abuse | 2025 | $1,825,990 | September 1, 2025 | May 31, 2030 | MOHAN, MAHESH | reporter.nih.gov |
| The Neural Underpinnings of Depression and Cannabis Use in Young PLWH | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,800,997 | September 1, 2021 | October 6, 2023 | GABBAY, VILMA | reporter.nih.gov |
| Gender and Sex Hormone Influences on Cannabis Use Disorder Remission | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,796,581 | July 1, 2021 | November 30, 2025 | TOMKO, RACHEL LYNN | reporter.nih.gov |
| Predictors and Consequences of Nicotine and Cannabis Vaping Co-use in Young Adults: A Longitudinal and EMA Analysis | NIH | National Cancer Institute | 2021 to 2025 | $1,795,774 | April 1, 2021 | March 31, 2027 | DUNBAR, MICHAEL | reporter.nih.gov |
| Targeting the Endocannabinoid System for Headache Intervention | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,793,296 | January 1, 2023 | December 31, 2027 | MILNES, TALLY MARIE | reporter.nih.gov |
| Stress-immune mechanisms for people living with HIV, CUD and Depression | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,790,616 | September 30, 2024 | May 31, 2029 | XU, KE | reporter.nih.gov |
| Astrocyte activity in amygdala-related fear conditioned behaviors | NIH | National Institute of Mental Health | 2021 to 2024 | $1,788,616 | June 1, 2020 | March 31, 2026 | ARAQUE, ALFONSO | reporter.nih.gov |
| Mechanisms and treatment of adolescent phytocannabinoid impairment of prefrontal cortex function | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,784,987 | May 1, 2022 | February 28, 2027 | LU, HUI-CHEN | reporter.nih.gov |
| AI-based Mapping of Complex Cannabis Extracts in Pain Pathways | NIH | National Center for Complementary & Integrative Health | 2023 to 2025 | $1,776,225 | February 14, 2023 | November 30, 2027 | VRANA, KENT E | reporter.nih.gov |
| Gene-environment interaction: the brain CRF system in alcohol preferring msP rats | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $1,774,951 | July 1, 2021 | June 30, 2027 | ROBERTO, MARISA | reporter.nih.gov |
| Mechanisms underlying the influence of stress on drug-seeking behavior | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,764,926 | July 1, 2023 | April 30, 2028 | MANTSCH, JOHN R | reporter.nih.gov |
| Lipid Imaging in Traumatic Brain Injury by High Resolution GCIB-secondary Ion Mass Spectrometry | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,756,092 | July 1, 2012 | July 31, 2028 | BAYIR, HÜLYA | reporter.nih.gov |
| Uncovering sleep and circadian mechanisms contributing to adverse metabolic health | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,755,898 | August 15, 2023 | July 31, 2027 | MCHILL, ANDREW WILLIAM | reporter.nih.gov |
| Activity-dependent endocannabinoid control in epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,751,643 | April 1, 2023 | March 31, 2028 | SOLTESZ, IVAN | reporter.nih.gov |
| Marijuana Use in Older Adults: Health, Function and Fall-Related Injury | NIH | National Institute on Aging | 2021 to 2023 | $1,738,546 | June 15, 2019 | February 28, 2026 | KEYHANI, SALOMEH | reporter.nih.gov |
| Cannabidiol and terpenoid interactions in amygdalar regulation of pain states | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $1,717,472 | May 1, 2022 | January 31, 2027 | LAND, BENJAMIN | reporter.nih.gov |
| Enteric glia and visceral pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,715,750 | March 1, 2024 | February 28, 2028 | GULBRANSEN, BRIAN D. | reporter.nih.gov |
| Cannabidiol-enhanced cognitive behavioral therapy for generalized anxiety disorder | NIH | National Institute of Mental Health | 2025 | $1,715,387 | June 1, 2025 | May 31, 2027 | MARUSAK, HILARY | reporter.nih.gov |
| Ecological Momentary Assessment of Negative Urgency's Effects on Alcohol and Marijuana Misuse | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,714,203 | July 15, 2019 | April 30, 2026 | KING, KEVIN MICHAEL | reporter.nih.gov |
| Investigation of Synthetic Cannabinoid Exposures and Pharmacological Consequences | NIH | National Institute on Drug Abuse | 2022 to 2025 | $1,708,678 | April 1, 2016 | May 31, 2028 | MAITRA, RANGAN | reporter.nih.gov |
| SIGNATURES OF CANNABIS ABUSE IN NEUROHIV (SCAN): AN INTEGRATED MOLECULAR AND IMAGING APPROACH | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,706,153 | September 15, 2018 | June 30, 2024 | WILSON, TONY W | reporter.nih.gov |
| Elucidating the mechanisms of cannabinoids on HIV-1 infection and inflammasome activation | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,704,831 | August 1, 2020 | June 30, 2025 | SWARTZ, TALIA H | reporter.nih.gov |
| Cannabis use and cardiovascular health outcomes among patients with high blood pressure | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,692,524 | September 15, 2023 | July 31, 2028 | ALSHAARAWY, OMAYMA O | reporter.nih.gov |
| Neuro-immune mechanisms of minor cannabinoids in inflammatory and neuropathic pain | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $1,692,291 | September 15, 2019 | June 30, 2025 | HELLMAN, JUDITH | reporter.nih.gov |
| Impact of THC on Extracellular Vesicle Signaling | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,685,105 | June 15, 2020 | April 30, 2026 | FOWLER, CHRISTIE D | reporter.nih.gov |
| Intestinal Homeostasis Induced by Commensals | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,680,144 | July 15, 2020 | April 30, 2025 | MCCORMICK, BETH A | reporter.nih.gov |
| Glutamatergic plasticity that drives cannabinoid withdrawal and craving | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,674,683 | September 1, 2023 | July 31, 2028 | SPENCER, SADE MONIQUE | reporter.nih.gov |
| Impact of Prescription Opioid Dose Changes on Cannabis Use and Clinical Outcomes | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,666,927 | August 1, 2019 | May 31, 2026 | MORASCO, BENJAMIN J. | reporter.nih.gov |
| A universal droplet microfluidic platform for ultrahigh-throughput biocatalyst evolution | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $1,654,892 | September 25, 2021 | August 31, 2025 | PRINCE, ROBIN | reporter.nih.gov |
| Exploring the anti-inflammatory properties of cannabis and their relevance to insulin sensitivity | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,652,097 | September 1, 2019 | May 31, 2026 | BRYAN, ANGELA | reporter.nih.gov |
| Circuit and Synaptic Mechanisms of Endocannabinoid-Opioid Crosstalk | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,647,735 | September 30, 2022 | June 30, 2027 | RAJADHYAKSHA, ANJALI M | reporter.nih.gov |
| Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,645,372 | March 1, 2023 | December 31, 2027 | LOGOTHETIS, DIOMEDES E. | reporter.nih.gov |
| Cerebellar biobehavioral markers in cannabis users | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,629,582 | April 15, 2019 | February 28, 2025 | HETRICK, WILLIAM P | reporter.nih.gov |
| Enhanced APOE2 Expression into Brain for Therapeutic Strategy for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $1,628,551 | May 15, 2021 | April 30, 2024 | SINGH, JAGDISH | reporter.nih.gov |
| Development of selective cannabinoid receptor 2 agonists for treatment of addiction | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,621,997 | April 19, 2022 | April 30, 2027 | SHAMLOO, MEHRDAD | reporter.nih.gov |
| Supplement to Basal Forebrain Modulation of Olfactory Bulb Function | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2022 | $1,608,566 | February 1, 2011 | August 31, 2023 | PUCHE, ADAM C | reporter.nih.gov |
| Activity-Dependent Plasticity in an Associative Hippocampal Circuit: Mechanisms, Synaptic Learning Rules and Involvement in Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,598,211 | August 1, 2019 | June 30, 2025 | CASTILLO, PABLO E | reporter.nih.gov |
| Molecular effects of cannabinoids on the Blood Brain Barrier in HIV-infected brain | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,588,360 | August 15, 2024 | May 31, 2029 | MARCONDES, MARIA CECILIA GARIBALDI | reporter.nih.gov |
| Identifying blood-based DNA methylation biomarkers of cannabis use | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,586,882 | September 30, 2020 | July 31, 2025 | FANG, FANG | reporter.nih.gov |
| Investigating mechanisms mediating enhanced THC reinforcement by nicotine | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,579,328 | July 1, 2023 | May 31, 2028 | TORREGROSSA, MARY M | reporter.nih.gov |
| Therapeutic and Mechanistic Evaluation of Cannabis sativa Terpenes in Neuropathic Pain | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $1,560,823 | July 1, 2021 | April 30, 2027 | STREICHER, JOHN MICHAEL | reporter.nih.gov |
| Cannabinoid modulation of EV composition and function in HIV/SIV infection | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,560,682 | August 1, 2022 | July 31, 2025 | OKEOMA, CHIOMA M | reporter.nih.gov |
| Novel therapeutic approach for NASH | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,553,952 | June 4, 2020 | May 31, 2025 | MAITRA, RANGAN | reporter.nih.gov |
| CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,551,552 | April 15, 2019 | February 28, 2026 | HOHMANN, ANDREA GRACE | reporter.nih.gov |
| CaV2.2 splice variants in the hippocampus: function and pharmacology | NIH | National Institute of Mental Health | 2022 to 2025 | $1,536,100 | July 1, 2022 | April 30, 2027 | ANDRADE, ARTURO | reporter.nih.gov |
| Modeling the effects of chronic marijuana use on neuroinflammation and HIV-related neuronal injury | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,527,736 | September 30, 2020 | August 31, 2026 | MEADE, CHRISTINA S | reporter.nih.gov |
| Characterizing Proximal Risk for Depressive Symptoms and Suicidal Ideation with Acute Cannabis Use and Withdrawal Among Adolescents Using Ecological Momentary Assessment | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,524,202 | July 1, 2024 | April 30, 2029 | SCHUSTER, RANDI MELISSA | reporter.nih.gov |
| Brain mechanisms of reducing polysubstance use following a novel body-mind intervention | NIH | National Center for Complementary & Integrative Health | 2023 to 2024 | $1,497,966 | March 1, 2019 | May 31, 2026 | TANG, YIYUAN | reporter.nih.gov |
| Exhaled breath drug detection using differential mobility spectrometry | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,496,677 | September 1, 2019 | December 31, 2024 | GOLDE, JACOB | reporter.nih.gov |
| Define the effects and mechanism of THC and CBD on IFN-I mediated inflammation and immune dysfunction during HIV infection | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,482,000 | September 30, 2020 | July 31, 2025 | ZHEN, ANJIE | reporter.nih.gov |
| Assessing Benefits and Harms of Medical Cannabis and Cannabinoid Use in Breast Cancer Patients During and After Treatments | NIH | National Cancer Institute | 2023 to 2025 | $1,471,480 | September 20, 2023 | August 31, 2029 | HU, JENNIFER J | reporter.nih.gov |
| Defining the impact of cannabinoids on the latent HIV reservoir through multi-omic analysis | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,460,156 | July 1, 2021 | June 30, 2027 | BROWNE, EDWARD P | reporter.nih.gov |
| Role of Microglia in Prenatal ethanol exposure-induced Impairment of Endocannabinoid Signaling | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $1,451,013 | September 22, 2022 | June 30, 2027 | SHEN, ROH-YU | reporter.nih.gov |
| Cannabis Use Impact on Pain and Recovery Post-Surgery - The Role of the Endocannabinoid System | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,443,561 | September 5, 2025 | August 31, 2030 | INGRAM, SUSAN L | reporter.nih.gov |
| A Chemoenzymatic Approach to Accessing Novel Isoprenoid Scaffolds | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,442,826 | January 1, 2022 | December 31, 2026 | SINGH, SHANTERI | reporter.nih.gov |
| Effects of THC on Retention of Memory for Fear Extinction Learning in PTSD | NIH | National Institute of Mental Health | 2021 to 2022 | $1,439,782 | February 24, 2017 | May 31, 2025 | RABINAK, CHRISTINE ANNE | reporter.nih.gov |
| Effect of Covid-19 on Caregivers of Persons with Dementia | NIH | National Institute on Aging | 2021 | $1,438,603 | September 1, 2016 | May 31, 2022 | ROSENBERG, PAUL B | reporter.nih.gov |
| Therapeutic Targeting of Monoacylglycerol Lipase After Traumatic Brain Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,436,743 | August 1, 2020 | April 30, 2026 | VAIBHAV, KUMAR | reporter.nih.gov |
| Targeting autophagy to reduce inflammasome-mediated inflammation and immune dysfunction in HIV and methamphetamine use | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,416,081 | June 1, 2024 | March 31, 2029 | ZHEN, ANJIE | reporter.nih.gov |
| Teaching Youth & Families Self-Regulation Skills to Disrupt the Impact of Adverse Childhood Experiences: Preventing Substance Use in Adversity-Impacted Youth | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,414,514 | July 1, 2024 | April 30, 2029 | BOUNDS, DAWN | reporter.nih.gov |
| Using behavioral economic domains to characterize cannabis use trajectories among young adults: A prospective mixed-methods investigation | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,411,234 | July 15, 2024 | April 30, 2029 | ASTON, ELIZABETH | reporter.nih.gov |
| Effects of Cannabis Species Labeling and Marketing on Perceptual, Subjective and Objective Use Outcomes | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,410,075 | July 1, 2024 | April 30, 2029 | MORAN, MEGHAN BRIDGID | reporter.nih.gov |
| Neural and Psychiatric Consequences of Cannabis Use in Adolescents | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,405,084 | September 30, 2024 | May 31, 2029 | GABBAY, VILMA | reporter.nih.gov |
| Impacts of drug abuse-mediated inflammatory perturbations on affinity maturation of anti-CD4 autoantibodies and poor immune reconstitution from ART in HIV | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,402,812 | September 30, 2024 | May 31, 2029 | JIANG, WEI | reporter.nih.gov |
| Cannabis effects on physical and mental health in medical cannabis patients | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,391,832 | June 15, 2024 | March 31, 2029 | CHUNG, TAMMY | reporter.nih.gov |
| Estrogen regulation of the prefrontal cortex and drug seeking | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,390,995 | July 1, 2020 | April 30, 2026 | MANTSCH, JOHN R. | reporter.nih.gov |
| Sleep-dependent synaptic homeostasis in Alzheimer's disease | NIH | National Institute on Aging | 2024 to 2025 | $1,390,274 | April 15, 2021 | March 31, 2027 | DIERING, GRAHAM HUGH | reporter.nih.gov |
| Efficacy of Brief Interventions to Reduce Comorbid Alcohol and Cannabis Misuse and Sleep Impairment in Young Adults | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $1,383,905 | June 5, 2024 | May 31, 2029 | LARIMER, MARY E. | reporter.nih.gov |
| An open road driving performance task to examine long-term medical marijuana use and prescription opioid positivity in adults 50 and older | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,375,269 | September 15, 2024 | May 31, 2029 | ENNIS, NICOLE | reporter.nih.gov |
| Biosynthesis and biological mechanism of minor cannabinoids | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $1,373,136 | December 20, 2023 | October 31, 2028 | MOORE, BRADLEY S | reporter.nih.gov |
| Stress, 'comfort' food, and obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,369,344 | May 8, 2020 | April 30, 2026 | ULRICH-LAI, YVONNE MICHELLE | reporter.nih.gov |
| Co-use of cannabis and prescription opioids in emerging adults in medical settings | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,363,572 | September 15, 2024 | May 31, 2029 | WILSON, ANNA CAMILLE | reporter.nih.gov |
| CB1-mediated signaling in developmental ethanol effects | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,355,828 | September 18, 2023 | June 30, 2028 | BALAPAL, BASAVARAJ S | reporter.nih.gov |
| Clinical Trial of Maternal Choline Supplements to Mitigate Effects of Prenatal Cannabis Exposure on Early Brain Development. | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,348,364 | May 1, 2024 | February 28, 2029 | HUNTER, SHARON K | reporter.nih.gov |
| Repeated Administration of Cannabis Varying in THC and CBD: Effects on Abuse Liability, Experimental Pain and Plasma Endocannabinoids | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,341,614 | August 15, 2022 | May 31, 2028 | HANEY, MARGARET | reporter.nih.gov |
| Alpha2delta-mediated control of neuronal signaling | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,338,101 | March 15, 2022 | February 28, 2027 | SCHNELL, ERIC | reporter.nih.gov |
| Effect of Cannabinoids on Tobacco Product Demand and Pharmacodynamics | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,337,048 | May 1, 2024 | February 28, 2029 | LEE, DUSTIN CLARK | reporter.nih.gov |
| Impact of Chronic Prenatal THC Exposure on SIV-associated Inflammation and Impairments in Placental and Fetal Development | NIH | National Institute on Drug Abuse | 2025 | $1,336,938 | September 1, 2025 | May 31, 2030 | MANUZAK, JENNIFER | reporter.nih.gov |
| Dynamics of Cannabis Market Environment Changes and Public Health Effects after Legalization: The Role of Local-Level Regulation Beyond the Short-Term in the Pacific Northwest | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,332,368 | September 15, 2015 | July 31, 2025 | DILLEY, JULIA ANN | reporter.nih.gov |
| Development of sterol carrier protein 2 inhibitors as anxiolytics | NIH | National Institute of Mental Health | 2024 to 2025 | $1,330,698 | July 1, 2024 | February 29, 2028 | HILLARD, CECILIA J | reporter.nih.gov |
| Health effects of cannabidiol vaping products | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,323,987 | March 1, 2024 | December 31, 2027 | REBULI, MEGHAN ELIZABETH | reporter.nih.gov |
| The role of endocannabinoids in circadian disruption induced metabolic dysregulation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,323,387 | December 1, 2019 | November 30, 2024 | KARATSOREOS, ILIA NICHOLAS | reporter.nih.gov |
| Neurobehavioral Impacts of Medical Cannabis Use: An Observational Study | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,317,120 | September 30, 2024 | May 31, 2029 | LUCIANA, MONICA | reporter.nih.gov |
| Structural basis for K2P channel gating and modulation | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,314,428 | September 1, 2022 | July 31, 2027 | BROHAWN, STEPHEN GRAF | reporter.nih.gov |
| Cannabis use and the endocannabinoid system in bipolar disorder | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,310,628 | May 1, 2018 | February 29, 2024 | PERRY, WILLIAM | reporter.nih.gov |
| Psychopharmacological effects of cannabidiol on responses to stress and nicotine withdrawal | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,303,839 | September 30, 2010 | February 28, 2029 | AL'ABSI, MUSTAFA | reporter.nih.gov |
| Effects of marijuana use on inflammation and vascular injury in adults with HIV infection | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,297,182 | April 1, 2018 | February 28, 2025 | GABUZDA, DANA H. | reporter.nih.gov |
| Population-Based Analyses of Healthcare Utilization and Outcomes in Users of Medical Marijuana | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,296,965 | September 30, 2021 | July 31, 2024 | THOMPSON, JOSEPH W | reporter.nih.gov |
| Comprehensive portrait of long-term cannabis users: Are they ready for old age? | NIH | National Institute on Aging | 2021 to 2024 | $1,291,760 | December 15, 2020 | November 30, 2025 | MOFFITT, TERRIE E | reporter.nih.gov |
| Next-Generation MEG Imaging for Quantifying Cortical-Subcortical Dynamics in the Context of HIV and Cannabis Use | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,280,701 | July 1, 2024 | April 30, 2029 | WILSON, TONY W. | reporter.nih.gov |
| The interplay of social, normative, and legal marijuana environments and marijuana and ATOD use from late childhood to young adulthood | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,280,351 | July 23, 2003 | June 30, 2025 | KUKLINSKI, MARGARET | reporter.nih.gov |
| Resource Center for Cannabis and Cannabinoid Research (R3CR) | NIH | National Center for Complementary & Integrative Health | 2025 | $1,260,872 | April 1, 2025 | March 31, 2030 | KHAN, IKHLAS AHMAD | reporter.nih.gov |
| Covid-19 pandemic and changes in the prevalence, patterns, and trajectories of substance use and related health risk outcomes among young adults in WA State: Administrative supplement. | NIH | National Institute on Drug Abuse | 2022 to 2024 | $1,260,659 | September 30, 2022 | July 31, 2025 | GUTTMANNOVA, KATARINA | reporter.nih.gov |
| A nonpsychoactive cannabinoid receptor-2 agonist to treat itch and inflammation in dermatomyositis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,259,835 | July 1, 2020 | June 30, 2025 | WERTH, VICTORIA P | reporter.nih.gov |
| Leveraging epidemiological data to inform the development of a just-in-time adaptive intervention for young adults co-using e-cigarettes and cannabis | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,258,187 | April 1, 2024 | March 31, 2026 | PHILLIPS, KRISTINA T. | reporter.nih.gov |
| Mechanisms of cannabinoid tolerance | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,242,514 | August 1, 2020 | July 31, 2024 | MORGAN, DANIEL J | reporter.nih.gov |
| Efficient synthon-based modular screening of Giga-to-Terra-scale virtual libraries | NIH | National Institute of General Medical Sciences | 2022 to 2024 | $1,237,500 | September 26, 2022 | June 30, 2025 | KATRITCH, VSEVOLOD | reporter.nih.gov |
| Intergenerational Studies Consortium: Understanding Mechanisms of Family Substance Use Transmission and Effects of Marijuana Legalization | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,235,266 | June 20, 2003 | May 31, 2024 | CAPALDI, DEBORAH M. | reporter.nih.gov |
| Cannabis use and health outcomes among opioid-using people who inject drugs in the context of cannabis legalization | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,234,770 | February 1, 2019 | November 30, 2024 | BLUTHENTHAL, RICKY N | reporter.nih.gov |
| Activity-dependent degradation of a neuromodulator | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,216,236 | July 1, 2019 | June 30, 2025 | LIU, SIQIONG JUNE | reporter.nih.gov |
| Leveraging Community-Engaged Research to Co-Create Youth Vaping Prevention with Urban Indigenous Communities of the Southwest | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,211,365 | September 1, 2024 | May 31, 2029 | VOLLRATH, STEPHANIE AYERS | reporter.nih.gov |
| Randomized controlled trial of varenicline to treat tobacco and cannabis co-use. | NIH | National Cancer Institute | 2024 to 2025 | $1,201,687 | June 1, 2024 | May 31, 2026 | MCCLURE, ERIN A | reporter.nih.gov |
| A Prospective Cohort Study of Patients with Non-Small Cell Lung Cancer and Multiple Myeloma to Assess the Benefits and Harms Related to Cannabis Use During Treatment | NIH | National Cancer Institute | 2023 to 2024 | $1,194,966 | September 20, 2023 | August 31, 2028 | LEE, RICHARD T | reporter.nih.gov |
| Endocannabinoid Mechanisms in the Pathophysiology of Alcohol Use Disorders | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $1,189,773 | September 1, 2017 | February 29, 2028 | PATEL, SACHIN | reporter.nih.gov |
| Analgesic efficacy of single and combined minor cannabinoids and terpenes | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $1,188,750 | September 15, 2019 | June 30, 2025 | WARD, SARA J | reporter.nih.gov |
| Randomized placebo controlled trial to determine the biological signature of cannabidiol as a treatment for social anxiety disorder | NIH | National Center for Complementary & Integrative Health | 2022 to 2023 | $1,180,991 | September 19, 2022 | February 28, 2026 | SIMON, NAOMI M | reporter.nih.gov |
| Circuit and Synaptic Mechanisms of Endocannabinoid-Opioid Crosstalk | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,157,008 | September 30, 2022 | October 31, 2023 | RAJADHYAKSHA, ANJALI M | reporter.nih.gov |
| Circuit-specific actions of endocannabinoids in stress and mood disorders | NIH | National Institute of Mental Health | 2021 to 2023 | $1,155,000 | September 11, 2019 | August 31, 2025 | LIU, QING-SONG | reporter.nih.gov |
| Developing and Strengthening Cannabis Warnings | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,152,425 | June 15, 2024 | March 31, 2029 | RANNEY, LEAH MARIE | reporter.nih.gov |
| Effects of host endocannabinoid signaling on Enterobacteriaceae infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,140,243 | June 6, 2024 | April 30, 2029 | ELLERMANN, MELISSA | reporter.nih.gov |
| REST-mediated regulation of opioid receptors in chronic pain mouse models | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,135,224 | July 1, 2020 | June 30, 2027 | MAJUMDER, SADHAN | reporter.nih.gov |
| Cannabis Relapse: Influence of Tobacco Cessation | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,109,799 | September 30, 2010 | June 30, 2025 | HANEY, MARGARET | reporter.nih.gov |
| Cannabis Legalization: Assessing its Impact on Treatment for Substance Use Disorders | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,104,943 | August 1, 2019 | May 31, 2025 | ALETRARIS, LYDIA | reporter.nih.gov |
| Metabolic correlates of disease activity and disability progression in pediatric MS | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,103,912 | April 1, 2021 | March 31, 2024 | WAUBANT, EMMANUELLE LAURENCE | reporter.nih.gov |
| Central Amygdala Glutamatergic Circuits in Fear Learning and Extinction | NIH | National Institute of Mental Health | 2021 to 2023 | $1,100,925 | April 21, 2022 | September 30, 2024 | PATEL, SACHIN | reporter.nih.gov |
| Endocannabinoid System Engagement and Clinical Symptom Change with Cannabidiol for Social Anxiety Disorder | NIH | National Center for Complementary & Integrative Health | 2022 to 2023 | $1,099,216 | January 18, 2022 | April 30, 2025 | TAYLOR, CHARLES | reporter.nih.gov |
| Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2022 | $1,083,127 | May 15, 2019 | November 30, 2024 | LONDON, EDYTHE DANICK | reporter.nih.gov |
| Impact of Cannabis on Prefrontal Maturation | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,079,325 | September 30, 2023 | June 30, 2028 | TSENG, KUEI-YUAN | reporter.nih.gov |
| Imaging Alterations in Endocannabinoid Metabolism in Depression and Suicide | NIH | National Institute of Mental Health | 2024 to 2025 | $1,078,719 | July 1, 2024 | January 31, 2029 | MIZRAHI, ROMINA | reporter.nih.gov |
| STATE MEDICAL CANNABIS LAWS, CHRONIC PAIN, AND OPIOIDS: A MIXED-METHODS APPROACH | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,064,118 | July 1, 2020 | April 30, 2025 | MCGINTY, EMMA ELIZABETH | reporter.nih.gov |
| Defining the impact of cannabinoids on the HIV reservoir in humanized mice | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,053,744 | September 30, 2023 | July 31, 2025 | BROWNE, EDWARD P | reporter.nih.gov |
| The GPR171 pathway in cancer immunotherapy | NIH | National Cancer Institute | 2023 to 2025 | $1,049,334 | April 25, 2023 | March 31, 2028 | ZHU, YUWEN | reporter.nih.gov |
| Behavioral Pharmacology of Synthetic Cannabinoids | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,048,107 | September 30, 2018 | June 30, 2024 | PARONIS, CAROL A | reporter.nih.gov |
| Approach Bias Modification for Co-Occurring Cannabis and Alcohol Use among Treatment-Seeking Adolescents | NIH | National Institute on Drug Abuse | 2021 to 2025 | $1,044,900 | April 1, 2021 | September 30, 2026 | HAHN, AUSTIN MATTHEW | reporter.nih.gov |
| Cannabinoid receptor control of a DRN to VTA pathway and its role in affective states | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,042,875 | March 1, 2019 | December 31, 2023 | CHEER, JOSEPH F | reporter.nih.gov |
| Cannabis Legalization's Effects on Youth and Adult Nicotine and Tobacco Use | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,037,639 | September 15, 2023 | July 31, 2028 | FRIEDMAN, ABIGAIL S. | reporter.nih.gov |
| Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,037,393 | August 15, 2022 | July 31, 2027 | STARK, RUTH E. | reporter.nih.gov |
| Endocannabinoid Biosynthesis in Inflammation and Pain | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,034,700 | February 1, 2024 | January 31, 2029 | HSU, KU-LUNG | reporter.nih.gov |
| Anti-inflammatory Effects of Novel Minor Cannabinoids and Terpenes on Cellular and Murine Models of HIV and HIV Proteins | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,034,538 | September 30, 2020 | July 31, 2025 | PARIS, JASON RICHARD | reporter.nih.gov |
| Synthesis of peripherally active CB1 agonists as analgesics | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,033,359 | September 29, 2021 | June 30, 2023 | MAJUMDAR, SUSRUTA | reporter.nih.gov |
| Alternative Splicing & Differential Expression of Lipases in Host-Microbe Interactions | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,030,241 | December 20, 2023 | October 31, 2028 | GHAZI, ARJUMAND | reporter.nih.gov |
| Gut-brain endocannabinoid signaling in feeding behavior and obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,021,476 | July 1, 2019 | March 31, 2025 | DIPATRIZIO, NICHOLAS VINCENT | reporter.nih.gov |
| THIS TASK ORDER (TO) IS TO PROVIDE DOSAGE FORM DEVELOPMENT, MANUFACTURE AND STABILITY STUDIES OF ORC-13661 FOR PHASE II CLINICAL TRIAL | NIH | National Institute on Drug Abuse | 2023 to 2024 | $1,008,087 | September 28, 2022 | July 31, 2027 | BOURQUE, TIM | reporter.nih.gov |
| Changes in cognition and psychiatric disorder symptoms during cannabis abstinence using a novel discordant twin design | NIH | National Institute on Drug Abuse | 2021 to 2025 | $1,001,888 | September 1, 2021 | August 31, 2026 | ROSS, JESSICA MEGAN | reporter.nih.gov |
| Prenatal Tobacco and Cannabis Exposure: A Translational Study | NIH | National Institute on Drug Abuse | 2021 to 2023 | $999,338 | September 30, 2018 | August 31, 2025 | THANOS, PANAYOTIS K | reporter.nih.gov |
| FABP5: Novel Functions in Pain Modulation | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $997,694 | March 1, 2024 | February 28, 2029 | KACZOCHA, MARTIN | reporter.nih.gov |
| Cultural and Environmental Influences on Precursors to and Early Stages of Alcohol, Nicotine, and Cannabis Use in Black and Latinx Youth | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $995,678 | December 8, 2021 | November 30, 2026 | SARTOR, CAROLYN E | reporter.nih.gov |
| Impacts of Recreational Marijuana Legalization and Retail Outlets in Washington: Unique Perspectives from Survey and County Mortality Data | NIH | National Institute on Drug Abuse | 2021 to 2022 | $986,098 | July 1, 2019 | May 31, 2024 | KERR, WILLIAM C. | reporter.nih.gov |
| Brain Mechanisms of Avoidance: Implications for Addiction and Anxiety | NIH | National Institute on Drug Abuse | 2021 to 2022 | $985,276 | September 30, 2018 | June 30, 2024 | LEDOUX, JOSEPH E | reporter.nih.gov |
| Advancing Varenicline as a Treatment for Cannabis Use Disorder | NIH | National Institute on Drug Abuse | 2021 | $981,666 | September 15, 2016 | July 31, 2024 | MCRAE-CLARK, AIMEE L | reporter.nih.gov |
| Cannabinoids Modulate Immune Cell-provoked Astrocyte Functions to Suppress HIV-Associated Neuroinflammatory Responses | NIH | National Institute on Drug Abuse | 2022 to 2023 | $976,880 | August 1, 2018 | May 31, 2025 | KAMINSKI, NORBERT E | reporter.nih.gov |
| State Medical Cannabis Laws, Chronic Pain, and Opioids: A Mixed-Methods Approach | NIH | National Institute on Drug Abuse | 2021 to 2022 | $970,075 | July 1, 2020 | September 11, 2022 | MCGINTY, EMMA ELIZABETH | reporter.nih.gov |
| Effects of Early-life Cannabinoid Exposure on Prefrontal Circuitry and Cognitive Behavior across Development | NIH | National Institute on Drug Abuse | 2024 to 2025 | $967,695 | June 1, 2024 | March 31, 2029 | CHE, ALICIA YUE | reporter.nih.gov |
| Partnering with Pregnant and Postpartum Women to Co-Create a Novel Intervention to Reduce Tobacco and Cannabis Use | NIH | National Institute on Drug Abuse | 2024 to 2025 | $963,792 | September 15, 2024 | August 31, 2027 | DE GENNA, NATACHA | reporter.nih.gov |
| Mentoring Clinical Researchers at the Intersection of NeuroHIV and Substance Abuse | NIH | National Institute on Drug Abuse | 2021 to 2025 | $959,325 | July 1, 2015 | June 30, 2027 | CHERNER, MARIANA | reporter.nih.gov |
| Cannabidiol Pharmacotherapy for Comorbid Opioid Addiction and Chronic Pain | NIH | National Institute on Drug Abuse | 2021 to 2025 | $958,500 | May 1, 2021 | April 30, 2026 | DE AQUINO, JOAO PAULO | reporter.nih.gov |
| Cannabis Toxicology in Relation to Neurocognitive Outcomes in Adolescents | NIH | National Institute on Drug Abuse | 2021 to 2025 | $956,790 | March 15, 2021 | February 28, 2027 | WADE, NATASHA E | reporter.nih.gov |
| Role of the circadian rhythm on endocannabinoid response to an acute stress | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $956,720 | January 1, 2021 | December 31, 2025 | BOWLES, NICOLE P | reporter.nih.gov |
| AI-Powered Biased Ligand Design | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $954,000 | May 1, 2023 | February 28, 2027 | WANG, JUNMEI | reporter.nih.gov |
| State-dependent interaction of antiepileptic drugs with voltage-dependent sodium channels and differential regulation of excitatory and inhibitory central neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $949,316 | February 1, 2019 | January 31, 2024 | BEAN, BRUCE P | reporter.nih.gov |
| Communication Bridge: Optimizing an evidence-based intervention for individuals with primary progressive aphasia | NIH | National Institute on Aging | 2021 to 2023 | $924,107 | September 15, 2017 | September 2, 2023 | ROGALSKI, EMILY J | reporter.nih.gov |
| The Effects of Cannabidiol on the Driving Performance of Healthy Adults | NIH | National Institute on Drug Abuse | 2024 to 2025 | $920,550 | September 1, 2024 | May 31, 2029 | RUDISILL, TONI MARIE | reporter.nih.gov |
| Exploring the Effects of Cannabinoids on Alcohol Consumption and the Microbiota-Gut-Brain Axis | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $909,791 | February 1, 2021 | December 31, 2024 | KAROLY, HOLLIS C | reporter.nih.gov |
| Cannabis effects on sleep, circadian rhythms, and light sensitivity in young people | NIH | National Institute on Drug Abuse | 2024 to 2025 | $905,371 | June 15, 2024 | April 30, 2029 | HASLER, BRANT P. | reporter.nih.gov |
| Cannabis Nexus Initiative II: Cannabis and Heart Rate Variability Study in HBCU Students | NIH | National Institute on Drug Abuse | 2021 to 2025 | $900,922 | September 1, 2021 | June 30, 2028 | KEEN, LARRY D | reporter.nih.gov |
| Cannabinoid inhibition of CNS inflammasome activation via modulation of the gut-brain axis | NIH | National Institute on Drug Abuse | 2025 | $898,025 | April 15, 2025 | February 28, 2030 | BYRAREDDY, SIDDAPPA N | reporter.nih.gov |
| Investigating the bidirectional relationship between circadian rhythms and cannabinoid use | NIH | National Institute on Drug Abuse | 2024 to 2025 | $887,766 | July 15, 2024 | May 31, 2029 | KETCHESIN, KYLE | reporter.nih.gov |
| Vulnerability and Persistence of Neuroinflammation and Behavioral Deficits from Developmental Cannabinoid Exposure | NIH | National Institute on Drug Abuse | 2024 to 2025 | $885,374 | July 1, 2024 | May 31, 2029 | WILLETT, KRISTINE L | reporter.nih.gov |
| Combination of THC and CBD as a Novel Treatment for Co-Occurring Opioid Addiction and Chronic Pain | NIH | National Institute on Drug Abuse | 2024 to 2025 | $883,050 | May 1, 2024 | February 28, 2028 | DE AQUINO, JOAO PAULO | reporter.nih.gov |
| Functional convergence following disruption of diverse genes associated with cannabis use and major depression | NIH | National Institute on Drug Abuse | 2024 to 2025 | $882,000 | September 1, 2024 | July 31, 2029 | GIRGENTI, MATTHEW J | reporter.nih.gov |
| Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection. | NIH | National Institute on Drug Abuse | 2023 to 2024 | $877,149 | April 15, 2021 | July 31, 2026 | OKEOMA, CHIOMA M | reporter.nih.gov |
| The role of stress physiology and reproductive hormones in the relationship between cannabis use and sleep in women of childbearing age | NIH | National Institute on Drug Abuse | 2024 to 2025 | $876,408 | September 1, 2024 | July 31, 2029 | SPAETH, ANDREA MARIE | reporter.nih.gov |
| Retail Environment for Tobacco and Marijuana in California: Impact on College Student Use | NIH | National Cancer Institute | 2021 to 2023 | $862,944 | February 1, 2018 | January 31, 2026 | HENRIKSEN, LISA ANNE | reporter.nih.gov |
| Chemical biology tools for illuminating cannabinoid signaling pathways in opioid use disorder. | NIH | National Institute on Drug Abuse | 2024 to 2025 | $842,400 | August 15, 2024 | May 31, 2029 | FRANK, JAMES ALLEN | reporter.nih.gov |
| Examining craving-choice interaction using computational modeling and intracranial recording | NIH | National Institute on Drug Abuse | 2025 | $836,348 | August 1, 2025 | April 30, 2030 | SAEZ, IGNACIO | reporter.nih.gov |
| Comparative Pharmacology of Cannabinoids in Rodent Models | NIH | National Institute on Drug Abuse | 2021 to 2022 | $832,915 | April 1, 2018 | December 31, 2025 | MARUSICH, JULIE A | reporter.nih.gov |
| Role of prelimbic cortical endocannabinoid signaling in enhanced cocaine-seeking behavior following combined repeated stress and cocaine use in rats | NIH | National Institute on Drug Abuse | 2024 to 2025 | $832,475 | March 1, 2024 | January 31, 2029 | MCREYNOLDS, JAYME ROSE | reporter.nih.gov |
| Highs or Lows? Evaluating the Benefits and Consequences of Medical Marijuana Use in Older Adults with Chronic Pain and Opioid Use | NIH | National Institute on Drug Abuse | 2021 to 2022 | $820,000 | September 30, 2019 | July 31, 2024 | GRUBER, STACI A | reporter.nih.gov |
| Development of a lifestyle physical activity intervention to reduce risk for perinatal cannabis use | NIH | National Institute on Drug Abuse | 2022 to 2024 | $818,130 | April 1, 2022 | February 28, 2026 | BATTLE, CYNTHIA L. | reporter.nih.gov |
| Identifying genetic sources of comorbidity between cannabis and schizophrenia using genome-wide and integrative omics data | NIH | National Institute on Drug Abuse | 2021 to 2025 | $815,532 | April 1, 2021 | March 31, 2027 | JOHNSON, EMMA COVEY | reporter.nih.gov |
| Strengthening Text-based Warning Labels on Cannabis Edible Packages | NIH | National Institute on Drug Abuse | 2025 | $811,679 | July 15, 2025 | April 30, 2030 | SHI, YUYAN | reporter.nih.gov |
| Co-Abuse Cannabis and Tobacco | NIH | National Institute on Drug Abuse | 2021 | $806,275 | September 1, 2017 | July 31, 2024 | MARUSICH, JULIE A | reporter.nih.gov |
| Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics | NIH | National Center for Complementary & Integrative Health | 2023 to 2024 | $797,291 | September 15, 2019 | June 30, 2026 | GAMAGE, THOMAS F | reporter.nih.gov |
| Pathophysiological mechanisms of cannabidiol in stress regulation | NIH | National Institute of Mental Health | 2025 | $794,696 | May 1, 2025 | February 28, 2030 | BACHI, KEREN | reporter.nih.gov |
| Quantifying effects of comorbidities and genetics on cannabinoid exposure in the elderly | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $794,611 | August 1, 2022 | February 28, 2026 | ZHOU, ZHU | reporter.nih.gov |
| FABPs: Novel Roles in Pain and Inflammation | NIH | National Institute on Drug Abuse | 2021 to 2022 | $790,902 | July 1, 2014 | May 31, 2024 | KACZOCHA, MARTIN | reporter.nih.gov |
| Cognitive flexibility and reward motivation in adolescent cannabis use: An investigation of neurobehavioral mechanisms and intrinsic resting state connectivity. | NIH | National Institute on Drug Abuse | 2021 to 2024 | $786,824 | April 1, 2021 | March 31, 2026 | THOMAS, SARAH ANN | reporter.nih.gov |
| Expanding Capacity for Addiction Regulatory Science Research and Mentoring | NIH | National Institute on Drug Abuse | 2021 to 2025 | $781,021 | April 1, 2019 | June 30, 2030 | LEVENTHAL, ADAM MATTHEW | reporter.nih.gov |
| Neuropathic Pain-induced Depression: the Role of mPFC Endocannabinoids | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $779,283 | August 15, 2019 | January 31, 2024 | PAN, BIN | reporter.nih.gov |
| Health outcomes and cognitive effects of marijuana use among persons living with HIV/AIDS | NIH | National Institute on Drug Abuse | 2021 | $777,541 | August 15, 2017 | March 31, 2023 | COOK, ROBERT L | reporter.nih.gov |
| The impact of medical cannabis on pain and inflammation in people living with HIV | NIH | National Institute on Drug Abuse | 2021 to 2024 | $776,700 | July 15, 2021 | February 28, 2026 | SLAWEK, DEEPIKA | reporter.nih.gov |
| Endocannabinoids in Neurodegenerative Diseases | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $774,165 | June 15, 2012 | April 30, 2023 | CHEN, CHU | reporter.nih.gov |
| Endocannabinoid Metabolism and Synaptic Function | NIH | National Institute of Mental Health | 2021 to 2022 | $773,125 | February 5, 2018 | November 30, 2023 | CHEN, CHU | reporter.nih.gov |
| Dronabinol for the reduction of chronic pain and inflammation in people with sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $773,104 | June 1, 2022 | May 31, 2027 | CURTIS, SUSANNA | reporter.nih.gov |
| Alcohol and Cannabis Misuse Among Assault-Injured Emerging Adults | NIH | National Institute on Drug Abuse | 2025 | $769,708 | May 15, 2025 | April 30, 2028 | COUPET, EDOUARD | reporter.nih.gov |
| Evaluation of the Smart Talk: Cannabis Awareness and Prevention Curriculum | NIH | National Institute on Drug Abuse | 2025 | $768,528 | June 1, 2025 | February 28, 2030 | HALPERN-FELSHER, BONNIE L | reporter.nih.gov |
| Understanding the Mechanistic Interrelationship between Sleep, Co-Occurring Cannabis and Alcohol Use Disorder, and Neurocircuit Dysfunction during Early Abstinence | NIH | National Institute on Drug Abuse | 2022 to 2023 | $768,436 | September 15, 2022 | August 31, 2025 | PADULA, CLAUDIA B. | reporter.nih.gov |
| The role of TREM2 in Alzheimer's disease related neuropathogenesis in people with HIV | NIH | National Institute on Aging | 2025 | $768,131 | July 1, 2025 | June 30, 2030 | FIELDS, JEREL ADAM | reporter.nih.gov |
| Connectome-based neuromarkers of problem cannabis use | NIH | National Institute on Drug Abuse | 2021 to 2024 | $766,800 | August 15, 2020 | July 31, 2025 | LICHENSTEIN, SARAH D. | reporter.nih.gov |
| Structure and Function of CB2 Receptor | NIH | National Institute on Drug Abuse | 2021 | $763,601 | September 30, 2017 | August 31, 2023 | MAKRIYANNIS, ALEXANDROS | reporter.nih.gov |
| Brain-Behavior Markers of Reward and Cannabis Abuse Risk in Young Adults | NIH | National Institute on Drug Abuse | 2021 to 2024 | $763,312 | July 15, 2020 | June 30, 2025 | CRANE, NATANIA A | reporter.nih.gov |
| CB1 receptors mediate metaplasticity in the cerebellar circuit | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $761,634 | March 1, 2024 | November 30, 2028 | PUGH, JASON RICHARD | reporter.nih.gov |
| Fetal neuronal extracellular vesicle biomarkers of in-utero effects of maternal cannabinoid use and human fetal brain development and neurobehavioral outcomes | NIH | National Institute on Drug Abuse | 2025 | $761,367 | September 1, 2025 | May 31, 2030 | GOETZL, LAURA | reporter.nih.gov |
| Endocannabinoid Control of Cholinergic Transmission and the Pursuit of Reward | NIH | National Institute of Mental Health | 2025 | $760,143 | May 1, 2025 | February 28, 2030 | CHEER, JOSEPH F | reporter.nih.gov |
| CHOICES-TEEN: Efficacy of a Bundled Risk Reduction Intervention for Juvenile Justice Females | NIH | National Institute on Drug Abuse | 2025 | $757,751 | April 1, 2025 | March 31, 2027 | PARRISH, DANIELLE ELIZABETH | reporter.nih.gov |
| The role of gut-heart axis in acute alcohol intoxication-induced adverse cardiovascular events | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $747,000 | August 1, 2023 | July 31, 2027 | PALOCZI, JANOS | reporter.nih.gov |
| Antidotes for Acute Cannabinoid Intoxication | NIH | National Institute on Drug Abuse | 2021 to 2022 | $746,997 | September 30, 2018 | July 31, 2024 | MAKRIYANNIS, ALEXANDROS | reporter.nih.gov |
| Role of Macrophages in CBD mediated attenuation of SEB-induced ARDS | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $746,874 | February 1, 2022 | July 31, 2026 | WILSON, KIESHA | reporter.nih.gov |
| Joint Impacts of Local Alcohol and Cannabis Laws and Outlet Densities on Violence | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2024 | $746,669 | May 17, 2022 | April 30, 2025 | MATTHAY, ELLICOTT COLSON | reporter.nih.gov |
| Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $746,308 | August 1, 2019 | August 31, 2023 | CAMILLERI, MICHAEL L. | reporter.nih.gov |
| Cannabinoid modulation of EV composition and function in HIV/SIV infection | NIH | National Institute on Drug Abuse | 2021 | $745,173 | September 30, 2019 | July 31, 2022 | OKEOMA, CHIOMA M | reporter.nih.gov |
| The Impact of Cannabis Use Disorder and its Treatment on Opioid-related Health Consequences: A Longitudinal Study of VA Patients | NIH | National Institute on Drug Abuse | 2025 | $744,875 | September 15, 2025 | May 31, 2030 | MANNES, ZACHARY L | reporter.nih.gov |
| Biochemistry of membrane proteins involved in lipid and cannabinoid metabolism | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $743,818 | August 1, 2024 | July 31, 2029 | DAS, ADITI | reporter.nih.gov |
| Development of an Alcohol, Cannabis, and Sexual Assault Risk Reduction Program for High Risk College Women | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $740,880 | March 5, 2021 | February 28, 2026 | LEONE, RUSCHELLE MARIE | reporter.nih.gov |
| Defining the impact of cannabinoids on the HIV reservoir in humanized mice | NIH | National Institute on Drug Abuse | 2025 | $738,616 | September 30, 2023 | July 31, 2028 | BROWNE, EDWARD P | reporter.nih.gov |
| The Effect of Antenatal Maternal Cannabis Use on Parenting Behavior | NIH | National Institute on Drug Abuse | 2022 to 2025 | $736,278 | April 1, 2022 | March 31, 2027 | SOKOL, NATASHA ALESSANDRA | reporter.nih.gov |
| Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain? | NIH | National Institute on Drug Abuse | 2021 | $733,464 | July 1, 2017 | June 30, 2024 | ARNSTEN, JULIA H. | reporter.nih.gov |
| Microglia-mediated adverse effect of cannabis on prefrontal cortex maturation and cognitive function | NIH | National Institute on Drug Abuse | 2025 | $727,497 | January 1, 2025 | November 30, 2029 | KAMIYA, ATSUSHI | reporter.nih.gov |
| DAT- Implementing routine screening for cannabis and other drug use disorders in primary care: impact on diagnosis and treatment in a randomized pragmatic trial in 22 clinics | NIH | National Institute on Drug Abuse | 2021 to 2022 | $726,750 | August 15, 2020 | July 31, 2025 | ANGERHOFER, JULIE ELISSA | reporter.nih.gov |
| Endocannabinoid-mediated neuroprotection in models of neuroAIDS in vivo | NIH | National Institute on Drug Abuse | 2021 to 2022 | $724,673 | June 1, 2018 | April 30, 2024 | FITTING, SYLVIA | reporter.nih.gov |
| Early life pain and its modulation by socioenvironmental factors: Implications for substance misuse | NIH | National Institute on Drug Abuse | 2024 to 2025 | $722,630 | August 15, 2024 | July 31, 2027 | BANGASSER, DEBRA A | reporter.nih.gov |
| Oral THC consumption during adolescence and its impact on adult mouse brain | NIH | National Institute on Drug Abuse | 2025 | $716,455 | July 1, 2025 | March 31, 2030 | STELLA, NEPHI | reporter.nih.gov |
| The Neural Underpinnings of Depression and Cannabis Use in Young PLWH | NIH | National Institute on Drug Abuse | 2024 | $709,068 | September 1, 2021 | July 31, 2026 | GABBAY, VILMA | reporter.nih.gov |
| Feasibility, Acceptability, and Efficacy of the Cannabis Awareness and Prevention Toolkit | NIH | National Institute on Drug Abuse | 2021 to 2023 | $708,375 | July 15, 2021 | June 30, 2025 | HALPERN-FELSHER, BONNIE L | reporter.nih.gov |
| Prenatal marijuana: Impact on infant neurobehavior, stress, & epigenetic mechanisms | NIH | National Institute on Drug Abuse | 2021 | $694,540 | September 1, 2017 | July 31, 2025 | STROUD, LAURA R | reporter.nih.gov |
| Recreational Marijuana Marketing and Young Adult Consumer Behavior | NIH | National Institute on Drug Abuse | 2021 | $693,912 | September 30, 2021 | April 12, 2022 | BERG, CARLA J | reporter.nih.gov |
| Role of cannabis on HIV-related cognitive impairment: a brain connectomics study | NIH | National Institute on Drug Abuse | 2022 to 2023 | $692,915 | July 15, 2018 | June 30, 2023 | MEADE, CHRISTINA S | reporter.nih.gov |
| Prospective changes in patient-reported and objective functioning following reduction of cannabis use | NIH | National Institute on Drug Abuse | 2025 | $686,692 | September 1, 2025 | July 31, 2030 | TOMKO, RACHEL LYNN | reporter.nih.gov |
| Telehealth-Delivered tDCS for Cannabis Addiction Recovery: The C.A.R.E.S. (Cannabis Addiction Recovery Enhancement Stimulation) Initiative | NIH | National Institute on Drug Abuse | 2025 | $684,694 | July 15, 2025 | June 30, 2027 | CHARVET, LEIGH | reporter.nih.gov |
| The impact of Cannabis on inflammation and HIV-1 reservoirs in Zambia | NIH | National Institute on Drug Abuse | 2021 | $683,905 | August 1, 2017 | November 30, 2021 | WOOD, CHARLES | reporter.nih.gov |
| Behavioral Pharmacology of Cannabinoid and Terpenoid Effects and Interactions | NIH | National Institute on Drug Abuse | 2021 | $677,123 | September 15, 2017 | April 30, 2024 | VANDREY, RYAN G | reporter.nih.gov |
| Development of non-opioid, non-addictive analgesics for treating neuropathic pain | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $675,107 | March 18, 2025 | January 31, 2030 | THAKUR, GANESH A | reporter.nih.gov |
| Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $672,377 | September 20, 2025 | August 31, 2030 | WOLINSKY, DAVID | reporter.nih.gov |
| The impact of Cannabis on inflammation and HIV-1 reservoirs in Zambia (Supplement 2) | NIH | National Institute on Drug Abuse | 2022 | $672,259 | August 1, 2017 | May 31, 2025 | WOOD, CHARLES | reporter.nih.gov |
| Neurodevelopmental Effects of THC on The VTA Dopamine System and Behavior | NIH | National Institute on Drug Abuse | 2021 to 2022 | $670,144 | September 30, 2018 | May 31, 2024 | CHEER, JOSEPH F | reporter.nih.gov |
| Quorum Sensing Regulation of EHEC Virulence Genes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $668,955 | July 1, 2003 | May 31, 2022 | SPERANDIO, VANESSA | reporter.nih.gov |
| Characterizing the Epidemiology of Cannabidiol (CBD) Use Among US adults | NIH | National Institute on Drug Abuse | 2022 to 2025 | $668,431 | April 1, 2022 | March 31, 2027 | LEAS, ERIC | reporter.nih.gov |
| Development and Acceptability Testing of a Technology-based Intervention to Reduce College Students' Cannabis Misuse | NIH | National Institute on Drug Abuse | 2024 | $668,110 | September 30, 2024 | September 29, 2027 | WILLOUGHBY, JESSICA FITTS | reporter.nih.gov |
| Biopsychosocial predictors of opioid use for pediatric postsurgical pain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $666,906 | May 1, 2021 | April 30, 2026 | STONE, AMANDA LEIGH | reporter.nih.gov |
| Development of selective cannabinoid receptor 2 agonists for treatment of addiction | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $661,980 | April 19, 2022 | March 31, 2023 | SHAMLOO, MEHRDAD | reporter.nih.gov |
| Analgesic potential of novel peripherally-restricted CB1 ligands | NIH | National Institute on Drug Abuse | 2025 | $660,290 | August 1, 2025 | April 30, 2030 | GEREAU, ROBERT W | reporter.nih.gov |
| Using Cannabinoids to Enhance Opioid Analgesic Effects in Humans | NIH | National Institute on Drug Abuse | 2021 | $657,143 | August 1, 2016 | June 30, 2023 | DUNN, KELLY E | reporter.nih.gov |
| Alcohol and Traumatic Brain Injury; Neuronal and Behavioral Consequences | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2022 | $657,000 | May 10, 2018 | March 31, 2024 | MOLINA, PATRICIA E. | reporter.nih.gov |
| Orexin modulation of brain reward-brain stress system interactions in alcohol withdrawal anxiety | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $654,468 | March 1, 2022 | February 28, 2027 | AVEGNO, ELIZABETH MINOR | reporter.nih.gov |
| An observational study of the effects of edible cannabis and its constituent cannabinoids on pain, inflammation, and cognition | NIH | National Center for Complementary & Integrative Health | 2021 | $654,019 | September 15, 2017 | August 31, 2024 | BIDWELL, L. CINNAMON | reporter.nih.gov |
| Elucidation of molecular mechanisms of prenatal cannabinoid exposure: Identification of targets and therapies | NIH | National Institute on Drug Abuse | 2021 to 2022 | $646,900 | April 15, 2020 | February 28, 2023 | SUPPIRAMANIAM, VISHNU D | reporter.nih.gov |
| Using Neuroimaging Markers to Understand Risk Factors and Consequences of Cannabis on Brain Structure and Function | NIH | National Institute on Drug Abuse | 2021 to 2025 | $641,520 | September 1, 2021 | August 31, 2026 | GILMAN, JODI | reporter.nih.gov |
| Cannabidiol and Macrophage Chronic Inflammation in a Virally Suppressed Rhesus Macaque Model | NIH | National Institute on Drug Abuse | 2024 | $640,462 | July 1, 2024 | June 30, 2026 | WILLIAMS, DIONNA WHITNEY | reporter.nih.gov |
| A multimethod examination of individual and environmental contributors to racial disparities in marijuana use | NIH | National Institute on Drug Abuse | 2021 | $640,243 | September 30, 2021 | September 29, 2023 | PEDERSEN, SARAH L | reporter.nih.gov |
| Medical Marijuana, Neurocognition, and Subsequent Substance Use | NIH | National Institute on Drug Abuse | 2021 | $636,868 | April 1, 2017 | January 31, 2024 | GILMAN, JODI | reporter.nih.gov |
| Cannabinoid CB2 Receptor Structure and Allosteric Modulators | NIH | National Institute on Drug Abuse | 2025 | $633,135 | July 15, 2021 | April 30, 2027 | XIE, XIANG-QUN | reporter.nih.gov |
| 2-Arachidonoylglycerol signaling in anxiety, depression, and stress adaptation | NIH | National Institute of Mental Health | 2021 | $628,506 | June 15, 2016 | January 1, 2022 | PATEL, SACHIN | reporter.nih.gov |
| Mobile health applications in adolescent marijuana use: assessing the interplay among sleep, pain and inhibitory control | NIH | National Institute on Drug Abuse | 2023 to 2025 | $623,104 | January 1, 2023 | December 31, 2027 | KOSSOWSKY, JOE | reporter.nih.gov |
| Examining the longitudinal impact of circulating endocannabinoid levels on neurocognition, impulsivity, and early cannabis use patterns in youth enrolled in the ABCD Study | NIH | National Institute on Drug Abuse | 2025 | $621,186 | July 1, 2025 | March 31, 2030 | LISDAHL, KRISTA MAURINE | reporter.nih.gov |
| Perinatal cannabinoids delay KCC2 expression and lead to neurodevelopmental abnormalities | NIH | National Institute on Drug Abuse | 2021 to 2022 | $619,214 | August 1, 2018 | June 30, 2024 | MACKIE, KENNETH | reporter.nih.gov |
| Single cell dark matter in the context of HIV and substance use | NIH | National Institute on Drug Abuse | 2025 | $616,372 | July 15, 2025 | March 31, 2030 | NIXON, DOUGLAS F | reporter.nih.gov |
| Brief Individual and Parent Interventions for Marijuana Misuse in Truant Adolescents | NIH | National Institute on Drug Abuse | 2021 | $615,951 | July 15, 2018 | April 30, 2024 | SPIRITO, ANTHONY | reporter.nih.gov |
| Evaluation of Marijuana and Opioid Drug Interactions: Assessment of the Safety Profile, Abuse-Related Pharmacodynamic Effects and Models of Drug Intake | NIH | National Institute on Drug Abuse | 2021 | $609,253 | August 1, 2018 | May 31, 2025 | BABALONIS, SHANNA | reporter.nih.gov |
| Elucidation of molecular mechanisms of prenatal cannabinoid exposure: Identification of targets and therapies. | NIH | National Institute on Drug Abuse | 2023 to 2024 | $602,700 | April 15, 2020 | February 28, 2026 | SUPPIRAMANIAM, VISHNU | reporter.nih.gov |
| Behavioral Economic Demand for Cannabis and Tobacco among Young Adult Dual Users | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $596,000 | August 1, 2022 | July 31, 2027 | PULVERS, KIMBERLEY | reporter.nih.gov |
| Using novel behavioral economic measures to characterize dual marijuana and tobacco use in young adults | NIH | National Cancer Institute | 2025 | $594,099 | December 1, 2024 | November 30, 2028 | ASTON, ELIZABETH | reporter.nih.gov |
| Impact of Marijuana Policies on Alcohol Use and Alcohol-Related Mortality | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $593,412 | September 1, 2018 | August 31, 2024 | NAIMI, TIMOTHY SIMONDS | reporter.nih.gov |
| Modeling weekly and daily processes of a high-risk feedback cycle of alcohol, cannabis, and nonmedical use of prescription stimulants in college students: Impacts on use, academics, and sleep | NIH | National Institute on Drug Abuse | 2025 | $589,440 | May 15, 2025 | February 28, 2030 | FAIRLIE, ANNE MARIE | reporter.nih.gov |
| Neurobehavioral Mechanisms of Choices to Smoke Cannabis in Cannabis Use Disorder | NIH | National Institute on Drug Abuse | 2021 | $586,571 | July 1, 2017 | May 31, 2024 | EVANS, SUZETTE M | reporter.nih.gov |
| Leveraging complementary big data methods and patient intervention designs to optimize neural markers of adolescent cannabis use | NIH | National Institute on Drug Abuse | 2023 to 2025 | $586,157 | September 1, 2023 | August 31, 2027 | TERVO-CLEMMENS, BRENDEN CRAIG | reporter.nih.gov |
| Feasibility/Acceptability of a Brief Motivational Intervention Integrating Online Personalized Feedback & Tailored Text Messages for Frequent/High-Intensity Cannabis Use in Post-Legalization Landscape | NIH | National Institute on Drug Abuse | 2024 to 2025 | $583,125 | August 1, 2024 | June 30, 2027 | LEE, CHRISTINE M | reporter.nih.gov |
| NEUROCOGNITIVE CONSEQUENCES OF ADOLESCENT MARIJUANA USE | NIH | National Institute on Drug Abuse | 2021 | $581,984 | February 15, 2017 | November 30, 2022 | ANOKHIN, ANDREY P. | reporter.nih.gov |
| Cannabis Legalization's Effects on Youth and Adult Nicotine and Tobacco Use | NIH | National Institute on Drug Abuse | 2023 | $581,021 | September 15, 2023 | July 31, 2028 | FRIEDMAN, ABIGAIL S. | reporter.nih.gov |
| Assessing Functional Outcomes Associated with Reductions in Cannabis Use | NIH | National Institute on Drug Abuse | 2021 | $580,651 | August 1, 2016 | July 31, 2023 | HSER, YIH-ING | reporter.nih.gov |
| Impact of State Cannabis Laws on Cancer Pain Management and Outcomes: A mixed-methods study | NIH | National Cancer Institute | 2024 | $578,284 | August 1, 2024 | February 28, 2025 | CHECK, DEVON | reporter.nih.gov |
| Preclinical assessment of a Sterol Carrier Protein-2 inhibitor in multidimensional opioid withdrawal. | NIH | National Institute on Drug Abuse | 2022 to 2024 | $573,400 | August 1, 2022 | July 31, 2025 | MOORE, CATHERINE FRANCES | reporter.nih.gov |
| A CB1 Antagonist for Treatment of Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $572,743 | September 1, 2024 | June 30, 2025 | ALAPAFUJA, SHAKIRU OLAJIRE | reporter.nih.gov |
| Novel approaches to understanding the role of cannabinoids and inflammation in anxiety | NIH | National Institute on Drug Abuse | 2021 | $562,633 | September 1, 2017 | June 30, 2024 | BIDWELL, L. CINNAMON | reporter.nih.gov |
| The Tobacco and Cannabis Retail Environment, Neighborhood Disadvantage, and Adolescent Vaping | NIH | National Institute on Drug Abuse | 2023 to 2025 | $561,117 | April 1, 2023 | March 31, 2028 | HARLOW, ALYSSA FITZPATRICK | reporter.nih.gov |
| Minor Cannabinoids and Terpenes: Preclinical Evaluation as Analgesics | NIH | National Center for Complementary & Integrative Health | 2021 to 2023 | $560,920 | September 15, 2019 | October 31, 2023 | GAMAGE, THOMAS F | reporter.nih.gov |
| Ambulatory Assessment of Simultaneous Alcohol and Marijuana Use: Impact on Alcohol Use and Consequences | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $560,766 | September 20, 2019 | August 31, 2024 | GUNN, RACHEL LYN | reporter.nih.gov |
| Long Term THC Elicits Distinct Changes in Adolescent Brain Dopamine Signaling | NIH | National Institute on Drug Abuse | 2021 | $555,359 | September 15, 2017 | January 31, 2023 | MADRAS, BERTHA K | reporter.nih.gov |
| Using Digital Tools to Understand Contexts and Consequences of High-THC Cannabis Use | NIH | National Institute on Drug Abuse | 2021 to 2023 | $553,764 | April 1, 2019 | March 31, 2025 | MEACHAM, MEREDITH | reporter.nih.gov |
| Cultural Adaptation of an Alcohol and Other Drug Use Treatment for Black Justice Involved Youth | NIH | National Institute on Drug Abuse | 2023 to 2025 | $552,944 | September 30, 2022 | August 31, 2027 | BRYANT, BRITTANY | reporter.nih.gov |
| The role of cannabinoid 1 receptor in age-associated diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $551,696 | September 12, 2025 | August 31, 2028 | KIM, YOO | reporter.nih.gov |
| Consequences of marijuana use on inflammatory pathways in HIV-infected youth | NIH | National Institute on Drug Abuse | 2021 | $542,130 | September 15, 2017 | July 31, 2023 | SLEASMAN, JOHN W. | reporter.nih.gov |
| Developing and Testing an Online Intervention for Decreasing Alcohol and Cannabis Misuse and Increasing Healthy Relationship Skills among Young Adult Couples: A Comprehensive Mixed-Methods Approach | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $536,962 | September 1, 2023 | August 31, 2028 | WALUKEVICH-DIENST, KATHERINE | reporter.nih.gov |
| Developing a Telehealth + mHealth Cannabis Use Intervention for Young Adults (MOMENT-V) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $534,000 | September 1, 2024 | August 31, 2027 | SHRIER, LYDIA A. | reporter.nih.gov |
| Imaging the Effects of Intermittent Thetaburst Stimulation on Cannabis Self-Administration in Heavy Cannabis Users | NIH | National Institute on Drug Abuse | 2021 to 2023 | $531,193 | August 1, 2021 | July 31, 2027 | KEARNEY-RAMOS, TONISHA EVETTE | reporter.nih.gov |
| Impact of State Cannabis Laws on Cancer Pain Management and Outcomes: A mixed-methods study | NIH | National Cancer Institute | 2025 | $527,872 | March 1, 2025 | July 31, 2029 | CHECK, DEVON | reporter.nih.gov |
| Pharmacokinetic and motivational properties of vaporized cannabis in mice | NIH | National Institute on Drug Abuse | 2022 to 2024 | $527,850 | September 30, 2022 | August 31, 2025 | MCLAUGHLIN, RYAN JOSEPH | reporter.nih.gov |
| Discovery of analgesic diterpenoid alkaloids from medicinal Aconitum plants using a metabolomic approach | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $527,283 | April 1, 2023 | March 31, 2027 | KENNELLY, EDWARD JAMES | reporter.nih.gov |
| Adapting and testing a behavioral intervention to prevent FASD and adverse infant outcomes | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $523,143 | September 22, 2022 | August 31, 2028 | WASHIO, YUKIKO | reporter.nih.gov |
| Refinement and Pilot Testing of a Computerized Distress Tolerance Intervention with Just-In-Time Text Message Reminders for Cannabis Use Disorder | NIH | National Institute on Drug Abuse | 2023 to 2025 | $517,610 | August 1, 2023 | July 2, 2025 | MACATEE, RICHARD | reporter.nih.gov |
| Multimodal Assessment of Cannabinoid Target Engagement in Adults with Obsessive-Compulsive Disorder | NIH | National Institute of Mental Health | 2021 to 2023 | $513,527 | July 1, 2021 | September 8, 2023 | KAYSER, REILLY REYNS | reporter.nih.gov |
| N-Acetylcysteine and Contingency Management for Youth Cannabis Use Disorder | NIH | National Institute on Drug Abuse | 2021 | $513,162 | March 15, 2017 | January 31, 2024 | GRAY, KEVIN M | reporter.nih.gov |
| Multiscale Insights into the Epigenetic Basis of THC Consumption | NIH | National Institute on Drug Abuse | 2025 | $507,000 | September 1, 2025 | May 31, 2030 | FERLAND, JACQUELINE-MARIE | reporter.nih.gov |
| A Behavioral Economic Intervention to Reduce Marijuana Use in Truant Youth | NIH | National Institute on Drug Abuse | 2021 to 2023 | $506,916 | April 15, 2019 | August 15, 2023 | YURASEK, ALI | reporter.nih.gov |
| Mechanisms mediating human enteroendocrine cell differentiation and function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $505,320 | August 1, 2023 | May 31, 2028 | ZEVE, DANIEL RICHARD | reporter.nih.gov |
| The influence of aerobic exercise on consolidation of fear extinction learning in PTSD | NIH | National Institute of Mental Health | 2023 to 2025 | $503,029 | March 3, 2023 | February 29, 2028 | CROMBIE, KEVIN M | reporter.nih.gov |
| Post-translational regulation of opioid and cannabinoid receptors | NIH | National Institute on Drug Abuse | 2021 | $498,194 | April 1, 2017 | March 31, 2023 | DEVI, LAKSHMI A | reporter.nih.gov |
| Simultaneous Alcohol and Marijuana Use: Momentary Influences and Consequences | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $495,603 | May 10, 2019 | April 30, 2025 | LINDEN-CARMICHAEL, ASHLEY NICOLE | reporter.nih.gov |
| Endocannabinoids and the development of extinction recall neural circuitry in adolescents | NIH | National Institute of Mental Health | 2021 to 2023 | $493,638 | July 1, 2019 | June 30, 2024 | MARUSAK, HILARY | reporter.nih.gov |
| Corticolimbic circuitry in adaptive stress coping behavior and subsequent alcohol drinking | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $493,384 | August 15, 2024 | July 31, 2027 | ORNELAS, LAURA C. | reporter.nih.gov |
| Oral Fluid Testing to Assess Cannabis Non-Use in Remote Clinical Trials | NIH | National Institute on Drug Abuse | 2025 | $489,500 | June 1, 2025 | May 31, 2027 | SHRIER, LYDIA A. | reporter.nih.gov |
| Targeting the endocannabinoid signaling in chemical threat agents-induced lung injury | NIH | National Institute of Environmental Health Sciences | 2025 | $489,008 | September 15, 2025 | September 14, 2027 | NAGRE, NAGARAJA | reporter.nih.gov |
| CHEMOPROTEOMIC METHODS FOR SERINE HYDROLASE INHIBITOR DEVELOPMENT | NIH | National Institute on Drug Abuse | 2021 | $486,911 | April 1, 2012 | March 31, 2022 | CRAVATT, BENJAMIN F | reporter.nih.gov |
| Convergence of Vitamin E, THC, Nicotine, Propylene Glycol and Glycerin Effects on Lung Inflammation When Vaped | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $486,616 | January 5, 2022 | December 31, 2026 | CROTTY ALEXANDER, LAURA ELISE | reporter.nih.gov |
| AOD Use Trajectories from Age 10 to 24: Multi-level Predictors, Health and Behavioral Functioning, and Racial/ethnic Disparities | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $486,001 | August 15, 2017 | June 30, 2023 | D'AMICO, ELIZABETH J. | reporter.nih.gov |
| Impact of cannabis legalization on prescription drug use and health outcomes in Connecticut | NIH | National Institute on Drug Abuse | 2023 to 2024 | $475,440 | April 1, 2023 | March 31, 2025 | RADHAKRISHNAN, RAJIV | reporter.nih.gov |
| Development of a digital therapeutic targeting anxiety sensitivity to reduce PTSD-SUD in women presenting for emergency care after sexual assault. | NIH | National Institute on Drug Abuse | 2023 to 2025 | $475,082 | March 1, 2023 | February 29, 2028 | SHORT, NICOLE AMAI | reporter.nih.gov |
| Cannabinoids as an environmental risk factor of testicular cancer: Assessment using cell culture models of human and mouse primordial germ cells and by exposure of pregnant mice | NIH | National Institute on Drug Abuse | 2024 to 2025 | $473,500 | May 15, 2024 | April 30, 2027 | SHIODA, TOSHIHIRO | reporter.nih.gov |
| A telehealth tDCS approach to decrease cannabis use: Towards reducing multiple sclerosis disability in multiple sclerosis | NIH | National Institute on Drug Abuse | 2022 to 2023 | $466,197 | March 15, 2022 | February 28, 2025 | CHARVET, LEIGH | reporter.nih.gov |
| Cannabis Hyperemesis Syndrome: An Increasing Challenge in Emergency Care | NIH | National Institute on Drug Abuse | 2021 to 2022 | $465,775 | July 1, 2021 | June 30, 2024 | WIGHTMAN, RACHEL | reporter.nih.gov |
| Effect of Cannabis Use on Synaptic Density in Older Adults | NIH | National Institute on Drug Abuse | 2021 to 2022 | $460,625 | September 30, 2021 | August 31, 2024 | RADHAKRISHNAN, RAJIV | reporter.nih.gov |
| Endocannabinoid System Alterations in Opioid Use Disorder (OUD) | NIH | National Institute on Drug Abuse | 2022 to 2023 | $460,625 | August 1, 2022 | July 31, 2024 | BASSIR NIA, ANAHITA | reporter.nih.gov |
| Acute effects of THC in older adults | NIH | National Institute on Drug Abuse | 2024 to 2025 | $460,625 | August 1, 2024 | July 31, 2027 | D'SOUZA, DEEPAK CYRIL | reporter.nih.gov |
| Cannabis, Human Milk, and Multi-omics | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $459,658 | December 8, 2023 | November 30, 2026 | MEEHAN, COURTNEY LYNNE | reporter.nih.gov |
| Using Machine Learning to predict daily PTSD and cannabis use disorder symptoms among non-treatment seeking veterans | NIH | National Institute on Drug Abuse | 2021 to 2022 | $458,891 | September 1, 2021 | August 31, 2024 | PEDERSEN, ERIC R. | reporter.nih.gov |
| Examination of potential effectiveness of transcranial direct current stimulation (TDCS) paired with reappraisal training for Cannabis Use Disorder | NIH | National Institute on Drug Abuse | 2024 to 2025 | $457,250 | July 1, 2024 | December 31, 2026 | POTENZA, MARC N | reporter.nih.gov |
| Interaction of cannabidiol (CBD) with targeted inhibitors of essential cancer signaling pathways | NIH | National Cancer Institute | 2023 to 2024 | $454,926 | April 1, 2023 | March 31, 2026 | GOLEMIS, ERICA A. | reporter.nih.gov |
| A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy | NIH | National Cancer Institute | 2022 | $452,540 | September 23, 2022 | August 31, 2025 | LEE, RICHARD T | reporter.nih.gov |
| Examining Motivations for and Quality of Alcohol and Marijuana Protective Behavior Strategy Use: Improving Prevention of Hazardous Young Adult Substance Use | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $451,389 | May 1, 2021 | August 31, 2024 | LEWIS, MELISSA A | reporter.nih.gov |
| The Role of Motivation and Control in Cannabis Use Disorders: A Cross-Cultural Longitudinal Neuroimaging Study | NIH | National Institute on Drug Abuse | 2021 | $450,776 | September 15, 2017 | June 30, 2024 | FILBEY, FRANCESCA | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of Colorado Denver | Aurora, CO | 22 | $33.6 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 22 | $32.3 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 16 | $30.7 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 19 | $29.9 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 20 | $28 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 20 | $26 million | 0 | $0 |
| University of Washington | Seattle, WA | 27 | $25.5 million | 0 | $0 |
| Yale University | New Haven, CT | 24 | $24.3 million | 0 | $0 |
| Brown University | Providence, RI | 15 | $19.6 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 17 | $18.3 million | 0 | $0 |
| University of Colorado at Boulder | Boulder, CO | 10 | $17.8 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 16 | $17.2 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 13 | $15.9 million | 0 | $0 |
| Duke University | Durham, NC | 10 | $14.9 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 10 | $14.7 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 12 | $14.5 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 11 | $14.1 million | 0 | $0 |
| New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC | New York, NY | 12 | $12.5 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 12 | $11.5 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 6 | $11.2 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 8 | $11.2 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 8 | $11 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 7 | $10.7 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 9 | $10.4 million | 0 | $0 |
| University of Florida | Gainesville, FL | 7 | $10.3 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 6 | $10.3 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 9 | $10.2 million | 0 | $0 |
| Research Triangle Institute | Research Triangle Park, NC | 10 | $10.1 million | 0 | $0 |
| Northeastern University | Boston, MA | 6 | $10 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 4 | $9.7 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 10 | $9.5 million | 0 | $0 |
| University of Mississippi | University, MS | 5 | $9.4 million | 0 | $0 |
| Washington University | Saint Louis, MO | 8 | $8.9 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 7 | $8.5 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 5 | $8 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 7 | $7.7 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 6 | $7.6 million | 0 | $0 |
| Stanford University | Stanford, CA | 12 | $7.4 million | 0 | $0 |
| Ohio State University | Columbus, OH | 5 | $7.2 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 7 | $7.1 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 4 | $6.7 million | 0 | $0 |
| Indiana University | Bloomington, IN | 7 | $6.4 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 4 | $5.9 million | 0 | $0 |
| Wayne State University | Detroit, MI | 4 | $5.9 million | 0 | $0 |
| Father Flanagan's Boys' Home | Boys Town, NE | 4 | $5.7 million | 0 | $0 |
| Mclean Hospital | Belmont, MA | 5 | $5.7 million | 0 | $0 |
| Washington State University | Pullman, WA | 12 | $5.6 million | 0 | $0 |
| Rand Corporation | Santa Monica, CA | 4 | $5.6 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 5 | $5.4 million | 0 | $0 |
| Texas A&m University Health Science CTR | College Station, TX | 4 | $5.3 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 4 | $5.3 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 6 | $5.3 million | 0 | $0 |
| Pennsylvania State Univ University Park | University Park, PA | 4 | $5.2 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 6 | $5.1 million | 0 | $0 |
| Texas Biomedical Research Institute | San Antonio, TX | 2 | $5.1 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 7 | $4.9 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 5 | $4.7 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 4 | $4.7 million | 0 | $0 |
| University of Tennessee Health Sci CTR | Memphis, TN | 2 | $4.7 million | 0 | $0 |
| LSU Health Sciences Center | New Orleans, LA | 10 | $4.6 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 5 | $4.6 million | 0 | $0 |
| Abalone Bio, Inc. | Emeryville, CA | 4 | $4.6 million | 0 | $0 |
| George Washington University | Washington, DC | 4 | $4.5 million | 0 | $0 |
| University of Wisconsin-Milwaukee | Milwaukee, WI | 3 | $4.2 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 6 | $4.1 million | 0 | $0 |
| University of Chicago | Chicago, IL | 2 | $3.8 million | 0 | $0 |
| Miriam Hospital | Providence, RI | 3 | $3.3 million | 0 | $0 |
| Georgetown University | Washington, DC | 1 | $3.3 million | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 2 | $3.3 million | 0 | $0 |
| CDM Group, Inc. | Bethesda, MD | 1 | $3.3 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 2 | $3.3 million | 0 | $0 |
| National Opinion Research Center | Chicago, IL | 1 | $3.3 million | 0 | $0 |
| Rutgers University New Brunswick | New Brunswick, NJ | 4 | $3.3 million | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 5 | $3.2 million | 0 | $0 |
| Baylor University | Waco, TX | 2 | $3.2 million | 0 | $0 |
| Queen's Medical Center | Honolulu, HI | 1 | $3.2 million | 0 | $0 |
| Drexel University | Philadelphia, PA | 1 | $3.1 million | 0 | $0 |
| Kannalife Sciences, Inc. | Lloyd Harbor, NY | 1 | $3 million | 0 | $0 |
| Schedule 1 Therapeutics, Inc. | Chicago, IL | 1 | $2.9 million | 0 | $0 |
| Dartmouth College | Hanover, NH | 2 | $2.8 million | 0 | $0 |
| Butler Hospital (providence, Ri) | Providence, RI | 2 | $2.8 million | 0 | $0 |
| Roswell Park Cancer Institute Corp | Buffalo, NY | 1 | $2.7 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 2 | $2.7 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 1 | $2.7 million | 0 | $0 |
| New York Medical College | Valhalla, NY | 3 | $2.7 million | 0 | $0 |
| University of Miami | Coral Gables, FL | 2 | $2.5 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 4 | $2.4 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 1 | $2.3 million | 0 | $0 |
| Fluid Discovery INC | San Francisco, CA | 3 | $2.2 million | 0 | $0 |
| Florida International University | Miami, FL | 3 | $2.2 million | 0 | $0 |
| University of California at Davis | Davis, CA | 1 | $2.2 million | 0 | $0 |
| BDH Pharma, LLC | Studio City, CA | 1 | $2.1 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 1 | $2.1 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 4 | $2.1 million | 0 | $0 |
| Invizyne Technologies, Inc. | Monrovia, CA | 1 | $2.1 million | 0 | $0 |
| Pure Green Pharmaceuticals, Inc. | West Bloomfield, MI | 1 | $2.1 million | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 3 | $2 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 1 | $2 million | 0 | $0 |
| Klein Buendel, Inc. | Golden, CO | 1 | $2 million | 0 | $0 |
| Cellibre INC | San Diego, CA | 1 | $2 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 393 | $193,643,389 | 0 | $0 |
| 2024 | 393 | $191,870,367 | 0 | $0 |
| 2023 | 394 | $189,218,883 | 0 | $0 |
| 2022 | 378 | $174,134,557 | 0 | $0 |
| 2021 | 356 | $168,118,642 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.